Alfa Chemistry (Page 550) @ ChemBuyersGuide.com, Inc.

IgG2 Protein, Human, Recombinant (S257A)
RHC-RP-1889
25 kDa (predicted); 34 kDa (reducing condition, du
Immunoglobulin heavy constant +¦ 2, Immunoglobulin heavy constant gamma 2, IgG2

IGG2, KAPPA FROM HUMAN MYELOMA PLASMA
IAR42411680

IGG2, LAMBDA FROM HUMAN MYELOMA PLASMA
IAR42411679

IgG2a IsoType Control, Azide Free
KL-AI-00362

IgG2a IsoType Control, Unconjugated
KL-AI-00363

IgG2a Protein, Mouse, Recombinant
RHC-RP-1877
26.4 kDa (predicted); 34 kDa (reducing condition,
Igh-1, IgG2a-Fc, 1816O9Rik

IgG2a Protein, Mouse, Recombinant, Biotinylated
RHC-RP-1943
26.4 kDa (predicted)
Igh-1, IgG2a-Fc, 1816O9Rik

IgG2a Protein, Rat, Recombinant
RHC-RP-1881
30-35 kDa (reducing condition)
Igg-2a, Ig +¦-2A chain C region, Ig gamma-2A chain C region

IGG2A, KAPPA FROM MURINE MYELOMA
IAR42411662

IGG2A, LAMBDA FROM MURINE MYELOMA
IAR42411667

IgG2b Protein, Mouse, Recombinant
RHC-RP-1886
26.3 kDa (predicted); 37 kDa (reducing condition,
IgG2b-Fc, IgG2b

IGG2B, KAPPA FROM MURINE MYELOMA
IAR42411658

IgG2C Protein, Mouse, Recombinant
RHC-RP-1928
26.10 kDa (predicted). Due to glycosylation, the p
Ighg2c, IgG2C

IgG3 Protein, Human, Recombinant
RHC-RP-1916
31.2 kDa (predicted); 38 kDa (reducing condition,
IGHG3

IgG3 Protein, Mouse, Recombinant
RHC-RP-1940
26 kDa (predicted); 33 kDa (reducing condition, du
IgG3-Fc, IgG3

IgG3, Anti-Mouse (rb), FITC Conjugated
ACMA00011024

IGG3, KAPPA FROM HUMAN MYELOMA PLASMA
IAR42411682

IGG3, KAPPA FROM MURINE MYELOMA
IAR42411689

IGG3, LAMBDA FROM HUMAN MYELOMA PLASMA
IAR42411681

IGG3, LAMBDA FROM MURINE MYELOMA
IAR42411668

IgG4 hFc Protein, Human, Recombinant (aa 99-326)
RHC-RP-1954
32 kDa (reducing condition)
IgG4 Fc, Ig +¦-4 chain C region, Ig gamma-4 chain C region

IgG4 Monoclonal Antibody (OTI4B12), Biotin-Conjugate
BR00001857

IgG4 Protein, Human, Recombinant (S108P)
RHC-RP-1878
25.5 kDa (predicted); 35 kDa (reducing condition,
IGHG4, IgG4 Fc

IGG4, LAMBDA FROM HUMAN MYELOMA PLASMA
IAR42411676

IgGGêÆFITC from human serum
IAR42411685

IGM ANTISERA, MONO-REAGENT
ACMA00013422

IGM FROM BOVINE SERUM
IAR42411698

IGM FROM HUMAN SERUM
IAR42411699

IgM IsoType Control , Unconjugated
KL-AI-00364

IGM, KAPPA FROM MURINE MYELOMA
IAR42411660

IGM, LAMBDA FROM MURINE MYELOMA
IAR42410811

IGOT1-01
CAS:882256-55-5
Trade Name: 4-(1H-indol-4-yl)-N-phenylpiperazine-1-carboxamide
Formula: C19H20N4O
ACM882256555
320.40
iGOT101; iGOT1 01; iGOT1-01; iGOT 101; iGOT-101

IGRD PEPTIDE
CAS:1392278-76-0
Formula: C35H57N13O14S2
ACLC1392278760
948 g/mol

IGSF11 Protein, Human, Recombinant (hFc)
RHC-RP-0116
55-70 kDa (reducing condition)
VSIG3, Igsf13, CXADRL1, CT119, BT-IgSF

IGSF11 Protein, Human, Recombinant (His)
RHC-RP-0313
24.6 kDa (predicted); 36 kDa (reducing condition,
VSIG3, immunoglobulin superfamily, member 11, Igsf13, CXADRL1, CT119, BT-IgSF

IGSF11 Protein, Mouse, Recombinant (His)
RHC-RP-0037
24.22 kDa (predicted). Due to glycosylation, the p
VSIG3, IgSF11, CXADRL1, CT119, Bt-IGSF, BtIGSF, Bt IGSF

IGSF3 Protein, Human, Recombinant (His)
RHC-RP-0006
126.6 kDa (predicted); 140 kDa (reducing condition
V8, LCDD, immunoglobulin superfamily, member 3, EWI-3

IGSF8 Protein, Human, Recombinant (His)
RHC-CD-3590
60 kDa (predicted); 63 kDa (reducing conditions)
PGRL, LIR-D1, KCT-4, immunoglobulin superfamily, member 8, EWI-2, EWI2, CD81P3, CD316

IGSF8 Protein, Mouse, Recombinant (hFc)
RHC-CD-3403
85.8 kDa (predicted); 80 kDa (reducing conditions)
R75384, PGRL, KCT-4, immunoglobulin superfamily, member 8, EWI-2, ESTM34, AU041109, AA033172

IGSF8 Protein, Mouse, Recombinant (His)
RHC-CD-3482
60.2 kDa (predicted); 66 kDa (reducing condition,
R75384, PGRL, KCT-4, immunoglobulin superfamily, member 8, EWI-2, ESTM34, AU041109, AA033172

IGURATIMOD
CAS:123663-49-0
Trade Name: N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide
Formula: C17H14N2O6S
PR123663490
374.4
Careram; Kolbet; T-614

IGURATIMOD
CAS:123663-49-0
Formula: C17H14N2O6S
PI123663490
374.37
N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide

IGURATIMOD
CAS:123663-49-0
AP123663490
374.37

IGURATIMOD
CAS:123663-49-0
Formula: C17H14N2O6S
ACLC123663490
374.37 g/mol

IGURATIMOD IMPURITY 1
CAS:2375563-22-5
Formula: C15H17NO6S2
APB2375563225
371.42

IGURATIMOD IMPURITY 10
CAS:149456-98-4
Formula: C17H18N2O6S
APB149456984
378.40
N-(2-(2-methoxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)formamide

IGURATIMOD IMPURITY 10
Formula: C17H18N2O8S2
APB11759
442.46

IGURATIMOD IMPURITY 11
CAS:149457-03-4
Formula: C16H16N2O6S
APB149457034
364.37
N-(2-(2-hydroxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)formamide

IGURATIMOD IMPURITY 11
Formula: C10H11ClN2O5S
APB11760
306.72

IGURATIMOD IMPURITY 12
Formula: C17H18N2O6S
APB11761
378.4

IGURATIMOD IMPURITY 13
Formula: C18H20N2O6S
APB11764
392.43

IGURATIMOD IMPURITY 14
Formula: C17H18N2O6S
APB11763
378.4

IGURATIMOD IMPURITY 15
Formula: C17H16N2O7S
APB11762
392.38

IGURATIMOD IMPURITY 16
Formula: C17H14N2O7S
APB11765
390.37

IGURATIMOD IMPURITY 17
Formula: C18H16N2O8S2
APB11767
452.45

IGURATIMOD IMPURITY 18
Formula: C11H9ClN2O5S
APB11766
316.17

Iguratimod Impurity 19 (Hydrochloride)
Formula: C10H13ClN2O4S-+HCl
APB01633
329.2
N-(4-(2-aminoacetyl)-2-chloro-5-methoxyphenyl)methanesulfonamide hydrochloride

IGURATIMOD IMPURITY 20
CAS:123663-50-3
Formula: C18H16N2O6S
APB123663503
388.39

Iguratimod Impurity 20 (Hydrochloride)
Formula: C17H20N2O7S2-+HCl
APB01634
464.94
N-(4-(2-aminoacetyl)-5-methoxy-2-phenoxyphenyl)-N-(methylsulfonyl)methanesulfonamide hydrochloride

IGURATIMOD IMPURITY 21
Formula: C11H13ClN2O5S
APB01635
320.75
N-(2-(5-chloro-2-methoxy-4-(methylsulfonamido)phenyl)-2-oxoethyl)formamide

IGURATIMOD IMPURITY 22
Formula: C18H18N2O7S
APB01631
406.41
N-(4-(2-formamidoacetyl)-5-methoxy-2-phenoxyphenyl)-N-(methylsulfonyl)formamide

IGURATIMOD IMPURITY 23
Formula: C18H20N2O8S2
APB01632
456.49
N-(2-(2-methoxy-4-(N-(methylsulfonyl)methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)formamide

IGURATIMOD IMPURITY 24
Formula: C10H11ClN2O5S
APB01630
306.72
N-(2-(5-chloro-2-hydroxy-4-(methylsulfonamido)phenyl)-2-oxoethyl)formamide

IGURATIMOD IMPURITY 25
Formula: C20H24N2O6S
APB01628
420.48
N-(2-(2-hydroxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)pivalamide

IGURATIMOD IMPURITY 27
Formula: C17H18N2O8S2
APB01629
442.46
N-(2-(2-hydroxy-4-(N-(methylsulfonyl)methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)formamide

IGURATIMOD IMPURITY 28
Formula: C14H15ClN2O3
APB11768
294.74

IGURATIMOD IMPURITY 28
CAS:1340086-28-3
Formula: C8H10ClNO3S
APB1340086283
235.69
N-(2-chloro-5-methoxyphenyl)methanesulfonamide

IGURATIMOD IMPURITY 29
Formula: C14H13NO6S
APB01627
323.32
2-hydroxy-4-(methylsulfonamido)-5-phenoxybenzoic acid

IGURATIMOD IMPURITY 3
Formula: C17H20N2O7S2
APB11753
428.47

IGURATIMOD IMPURITY 3
CAS:76838-72-7
Formula: C13H13NO2
APB76838727
215.25
5-methoxy-2-phenoxyaniline

IGURATIMOD IMPURITY 30
Formula: C15H17NO6S2
APB01626
371.43
N-(5-methoxy-2-phenoxyphenyl)-N-(methylsulfonyl)methanesulfonamide

IGURATIMOD IMPURITY 30
CAS:123663-48-9
Formula: C16H14N2O5S
APB123663489
346.36

IGURATIMOD IMPURITY 31
Formula: C21H26N2O6S
APB01625
434.51
N-(2-(2-methoxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)pivalamide

Iguratimod Impurity 32
Formula: C17H14N2O7S
APB11769
390.37

Iguratimod Impurity 32 (Hydrochloride)
CAS:149436-41-9
Formula: C16H18N2O5S-+HCl
APB149436419
386.85
N-(4-(2-Aminoacetyl)-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride

Iguratimod Impurity 33
CAS:1179354-65-4
Formula: C18H16N2O6S
APB1179354654
388.39
N-(7-(N-methylmethylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide

Iguratimod Impurity 33
CAS:150831-14-4
Formula: C15H16N2O5S
APB150831144
336.36

Iguratimod Impurity 34
Formula: C15H16N2O3
APB11770
272.3

Iguratimod Impurity 34 (Hydrochloride)
Formula: C15H16N2O5S-+HCl
APB01624
372.82
N-(4-(2-Aminoacetyl)-5-hydroxy-2-phenoxyphenyl)methanesulfonamide hydrochloride

Iguratimod Impurity 35
Formula: C17H18N2O6S
APB01623
378.40
N-(2-(2-hydroxy-4-(N-methylmethylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)formamide

Iguratimod Impurity 35
CAS:10298-80-3
Formula: C7H6ClNO3
APB10298803
187.58

Iguratimod Impurity 36
Formula: C18H20N2O6S
APB01622
392.43
N-(1-(2-hydroxy-4-(N-methylmethylsulfonamido)-5-phenoxyphenyl)-1-oxopropan-2-yl)formamide

Iguratimod Impurity 37
Formula: C19H18N2O6S
APB01620
402.42
N-methyl-N-(7-(N-methylmethylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide

Iguratimod Impurity 38
Formula: C17H14N2O7S
APB01619
390.37
N-(7-(N-hydroxymethylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide

Iguratimod Impurity 39
Formula: C21H22N2O6S
APB11771
430.48

IGURATIMOD IMPURITY 4
Formula: C10H13ClN2O4S
APB11756
292.73

IGURATIMOD IMPURITY 4
CAS:123664-84-6
Formula: C14H15NO4S
APB123664846
293.34
N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide

Iguratimod Impurity 40
Formula: C18H20N2O6S
APB11772
392.43

Iguratimod Impurity 41
Formula: C16H15ClN2O5S
APB11773
382.82

Iguratimod Impurity 43
Formula: C15H15NO6S
APB11774
337.35

Iguratimod Impurity 43 (Hydrochloride)
Formula: C16H14N2O6S-+HCl
APB01621
398.82
N-(3-amino-4-oxo-6-phenoxy-4H-chromen-7-yl)-N-hydroxymethanesulfonamide hydrochloride

Iguratimod Impurity 46
CAS:16156-59-5
Formula: C7H8O3S
APB16156595
172.2

Iguratimod Impurity 47
Formula: C15H15NO6S
APB01618
337.35
2-methoxy-4-(methylsulfonamido)-5-phenoxybenzoic acid

Iguratimod Impurity 48
CAS:144150-51-6
Formula: C9H10ClNO5S
APB144150516
279.69

Iguratimod Impurity 49
Formula: C15H14N2O5
APB11775
302.29

IGURATIMOD IMPURITY 5
Formula: C18H20N2O8S2
APB11755
456.48

IGURATIMOD IMPURITY 5
CAS:2401-24-3
Formula: C7H8ClNO
APB2401243
157.60
2-Chloro-5-methoxyaniline

Iguratimod Impurity 50
Formula: C14H11NO6
APB11777
289.24

Iguratimod Impurity 51
Formula: C14H13NO4
APB11776
259.26

Iguratimod Impurity 53
Formula: C8H8BrNO3
APB01617
246.06
methyl 4-amino-3-bromo-2-hydroxybenzoate

IGURATIMOD IMPURITY 6
Formula: C11H13ClN2O5S
APB11754
320.74

IGURATIMOD IMPURITY 7
Formula: C19H18N2O8S
APB11757
434.42

IGURATIMOD IMPURITY 8
Formula: C18H18N2O7S
APB11758
406.41

IGURATIMOD IMPURITY 8
CAS:149456-97-3
Formula: C18H20N2O6S
APB149456973
392.43
N-(2-(2-methoxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)acetamide

IGURATIMOD IMPURITY 9
CAS:149457-04-5
Formula: C17H18N2O6S
APB149457045
378.40
N-(2-(2-hydroxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)acetamide

IGURATIMOD IMPURITY 9
CAS:544482-14-6
Formula: C18H18N2O7S
APB544482146
406.41

Iguratimod Impurity D
Formula: C11H9ClN2O5S
APB01641
316.72
N-(6-chloro-7-(methylsulfonamido)-4-oxo-4H-chromen-3-yl)formamide

Iguratimod Impurity E
CAS:123662-92-0
Formula: C18H16N2O6S
APB123662920
388.39
N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)acetamide

Iguratimod Impurity F
Formula: C21H22N2O6S
APB01640
430.47
N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)pivalamide

Iguratimod Impurity G
Formula: C18H14N2O7S
APB01639
402.38
N-(3-formamido-4-oxo-6-phenoxy-4H-chromen-7-yl)-N-(methylsulfonyl)formamide

Iguratimod Impurity H
Formula: C18H16N2O8S2
APB01638
452.46
N-(7-(N-(methylsulfonyl)methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide

Iguratimod Impurity I (Hydrochloride)
Formula: C16H14N2O5S-+HCl
APB01637
382.82
N-(3-Amino-4-oxo-6-phenoxy-4H-chromen-7-yl)methanesulfonamide hydrochloride

Iguratimod Impurity J
Formula: C16H12N2O4
APB01636
296.28
N-(7-amino-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide

IH-INDENE,2,3,3A,4,7,7A-HEXAHYDRO-2,2,4,4,7,7-HEXAMETHYL-
CAS:61142-60-7
ACM61142607

IHC Select Secondary Goat Anti-Mouse IgG Antibody, prediluted, biotinylated
BR00003720

IHC Select Secondary Goat Anti-Rabbit IgG Antibody, prediluted, biotinylated
BR00003721

IHDA
CAS:2536-36-9
Formula: C16H31IO2
ACM2536369

IHIC
CAS:2127354-15-6
Formula: C90H80N4O2S4
ACM2127354156
1377.88

IHN 42710
CAS:2055042-71-0
Trade Name: N2-(4,7,10,13-tetraoxahexadec-15-ynoyl)-N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-
Formula: C28H46N4O9S
BR00028559
614.76 g/mol
N-(Propargyl-PEG4)-biocytin; IHN 42710; IHN-42710; IHN42710

IHR-1
CAS:548779-60-8
AP548779608
454.13

IIDQ
CAS:38428-14-7
Trade Name: 2-methylpropyl 2-(2-methylpropoxy)-2H-quinoline-1-carboxylate
Formula: C₁₈H₂₅NO₃
ACM38428147
303.4
IIDQ, 178241_ALDRICH, 58625_FLUKA, EINECS 253-925-9, CID100621, NSC332545, NSC 332545, ST5308556, Isobutyl 2-isobutoxy-2H-quinoline-1-carboxylate, 1-Isobutoxycarbonyl-2-isobutoxy-1,2-dihydroquinoline, 2-Isobutoxy-1-isobutoxycarbonyl-1,2-dih

III Reverse Transcriptase (Glycerol-free)
BM-IVD-065

III-31-C
CAS:398515-96-3
AP398515963
640.81

III-31-C
CAS:398515-96-3
Formula: C₃₅H₅₂N₄O₇
ACM398515963
640.81

III-63 HYDRATE
CAS:714252-21-8
Trade Name: N-(2-methylphenyl)-4-(2-methylpropoxy)benzamide
Formula: C₆₀H₈₀N₈O₉S??-+xH₂O
ACM714252218
1089.39 (anhydrous b

IINFRARED ABSORBER 780 IODIDE
CAS:207399-07-3
Formula: C36H44ClN2
ACM207399073-1
667.12
2-[2-[2-Chloro-3-[(1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene]-1-cyclohexen-1-yl]ethenyl]-3,3-dimethyl-1-propylindolium iodide

IISERP-COF4
CAS:1788078-55-6
ACM1788078556-2

IKAP Polyclonal Antibody, Biotin-Conjugate
BR00003038

IKARISOSIDE A
CAS:55395-07-8
Formula: C26H28O10
ACM55395078-1
500.49
Baohuoside II

IKARISOSIDE F
CAS:113558-14-8
Formula: C31H36O14
ACM113558148
632.61

IKARISOSIDE F
CAS:113558-14-8
Formula: C31H36O14
ACM113558148-1
632.61
Ikarisoside-F

IKARISOSIDE F
CAS:113558-14-8
Formula: C31H36O14
ALPE113558148
632.62 g/mol

IKARUGAMYCIN
CAS:36531-78-9
Formula: C₂₉H₃₈N₂O₄
ACM36531789
478.62
TU-6239 C3;IKARUGAMYCIN

IKARUGAMYCIN
CAS:36531-78-9
Formula: C29H38N2O4
ACM36531789-1
478.62

IKARUGAMYCIN
CAS:36531-78-9
AP36531789
478.62

IKB alpha Monoclonal Antibody (2A5), Biotin-Conjugate
BR00001929

IKIX1
CAS:656222-54-7
AP656222547
303.17

IKK +¦ , active, GST tagged human
IAR42416190

IKK gamma Polyclonal Antibody, Biotin-Conjugate
BR00002633

IKK INHIBITOR III, BMS-345541
CAS:445430-58-0
Formula: C14H17N5-+2C2HF3O2
ACLC445430580
483.36 g/mol

IKK+¦ Recombinant Human Active Protein Kinase
NZs001467

Ikk-+¦, gst tagged human
IAR42417864

IKK-16 DIHYDROCHLORIDE
IAR4243672
556.55

IKSHUSTEROL
CAS:34427-61-7
Trade Name: (3S,7S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11
Formula: C29H50O2
ACM34427617
430.7

IKSHUSTEROL
CAS:34427-61-7
Formula: C29H50O2
ACM34427617-1
430.71

IKSHUSTEROL
CAS:34427-61-7
Formula: C29H50O2
ALPE34427617
430.71

IKSHUSTEROL 3-O-GLUCOSIDE
CAS:112137-81-2
Trade Name: (2R,3R,4S,5S,6R)-2-[[(3S,7S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-7-hydrox
Formula: C35H60O7
ACM112137812
592.9

IKSHUSTEROL 3-O-GLUCOSIDE
CAS:112137-81-2
Formula: C35H60O7
ACM112137812-1
592.85

IKSHUSTEROL 3-O-GLUCOSIDE
CAS:112137-81-2
Formula: C35H60O7
ALPE112137812
592.85

IKZF-IN-1
Formula: C26H28FN5O4
ACM-MG-00023
493.53

IKZF1 Protein, Human, Recombinant (Avi & His)
RHC-OTH-0616
56.8 kDa (predicted)
Lymphoid transcription factor LyF-1, IKZF1, Ikaros family zinc finger protein 1, DNA-binding protein Ikaros

IKZF1-degrader-1
CAS:2915586-02-4
Trade Name: 4-[4-[[4-[[1-[(3S)-2,6-dioxopiperidin-3-yl]-4-fluoro-2-oxobenzo[cd]indol-6-yl]methyl]phenyl]methyl]p
Formula: C35H29F2N5O3
ACM-MG-2915586024
605.63

IKZF1-degrader-2
CAS:2915330-86-6
Trade Name: (4aR)-3-[[4-[[2-[(3S)-2,6-dioxopiperidin-3-yl]-6-fluoro-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]meth
Formula: C33H30FN5O5
ACM-MG-2915330866
595.62

IKZF2-degrader 1
CAS:2983840-43-1
Formula: C27H30FN7O3
ACM-MG-2983840431
519.57

IKZF3 degrader 1
Formula: C25H18BrCl3N2O5
ACM-MG-00022
612.68

IKZF3 Monoclonal Antibody (OTI2B9), Biotin-Conjugate
BR00001823

IKZF3 Monoclonal Antibody (OTI4C9), Biotin-Conjugate
BR00001824

IKZF3 Monoclonal Antibody (OTI5H2), Biotin-Conjugate
BR00001822

IKZF3 Monoclonal Antibody (OTI7E11), Biotin-Conjugate
BR00001832

IL -17C Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0371
24-26 kDa (reducing condition)
interleukin-17C, interleukin 17C, IL-17CMGC126884, IL-17C, IL17C, Cytokine CX2, CX2

IL-1 alpha Monoclonal Antibody (840C20B8), Biotin-Conjugate
BR00001101

IL-1 alpha Monoclonal Antibody (ILA8-H12), Biotin-Conjugate
BR00000456

IL-1 alpha Polyclonal Antibody, Biotin-Conjugate
BR00000520

IL-1 alpha/IL-1A Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0196
19.23 kDa (predicted). Due to glycosylation, the p
Interleukin-1 +¦, Interleukin-1 alpha, IL1+¦, IL1F1, IL-1A, IL1A, IL-1 +¦/IL-1A, IL-1 +¦, IL-1 alpha, IL1, Hematopoietin-1

IL-1 alpha/IL-1A Protein, Human, Recombinant
RHC-CGF-0122
18 kDa (predicted); 22 kDa (reducing condition, du
interleukin 1, +¦, interleukin 1, alpha, IL1-+¦, IL-1F1, IL1F1, IL1-ALPHA, IL-1A, IL-1 +¦/IL1A, IL1

IL-1 alpha/IL-1A Protein, Human, Recombinant (Avi), Biotinylated
RHC-CGF-0279
19 kDa (reducing condition)
Interleukin-1 +¦, Interleukin-1 Alpha, IL1F1, IL1A, IL-1 +¦, IL-1 Alpha, Hematopoietin-1

IL-1 alpha/IL-1A Protein, Human, Recombinant (E. coli)
RHC-CGF-0140
The recombinant human IL1A consists 159 amino acid
interleukin 1 +¦, interleukin 1 alpha, IL1-+¦, IL-1F1, IL1F1, IL1-ALPHA, IL-1A, IL-1 +¦/IL1A, IL1

IL-1 alpha/IL-1A Protein, Human, Recombinant (hFc)
RHC-CGF-0092
54 kDa (reducing condition)
Interleukin-1 +¦, Interleukin-1 Alpha, IL1F1, IL1A, IL-1 +¦, IL-1 Alpha, Hematopoietin-1

IL-1 alpha/IL-1A Protein, Mouse, Recombinant
RHC-CGF-0130
18 kDa (predicted); 18 kDa (reducing conditions)
interleukin 1, +¦, interleukin 1, alpha, Il-1a, IL-1 +¦/IL1A

IL-1 alpha/IL-1A Protein, Rat, Recombinant
RHC-CGF-0221
17.80 kDa (predicted)
interleukin 1, +¦, interleukin 1, alpha, IL-1 +¦/IL1A

IL-1 alpha/IL1A Protein, Rhesus macaque, Recombinant (His & SUMO)
RHC-CGF-0234
34.1 kDa (predicted)
Interleukin-1 alpha, IL1A, Hematopoietin-1

IL-1 beta Monoclonal Antibody (1400.24.17), Biotin-Conjugate
BR00000315

IL-1 beta Monoclonal Antibody (508A3H12), Biotin-Conjugate
BR00000635

IL-1 beta Monoclonal Antibody (CRM57), Biotin-Conjugate
BR00000327

IL-1 beta Monoclonal Antibody (ILB1-H6), Biotin-Conjugate
BR00000321

IL-1 beta Polyclonal Antibody, Biotin-Conjugate
BR00000333

IL-1 beta Protein, Sheep, Recombinant (His)
RHC-CGF-0202
19.7 kDa (predicted)
Interleukin-1 beta, IL1B

IL-1 beta Protein, Zebrafish, Recombinant (His & Myc)
RHC-CGF-0280
32.9 kDa (predicted)
Interleukin-1, il1b

IL-1 beta Protein, Zebrafish, Recombinant (His)
RHC-CGF-0276
29.9 kDa (predicted)
Interleukin-1, il1b

IL-1 beta/IL-1F2 Protein, Canine, Recombinant
RHC-CGF-0293
17.6 kDa (predicted); 17 kDa (reducing conditions)
interleukin 1, +¦, interleukin 1, beta, IL-1 +¦

IL-1 beta/IL-1F2 Protein, Cavia porcellus, Recombinant (His)
RHC-CGF-0316
16-19 kDa (reducing condition)
Interleukin-1 +¦, Interleukin-1 beta, IL1B, IL-1 +¦, IL-1 beta

IL-1 beta/IL-1F2 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0261
18.33 kDa (predicted) same as Tris-Bis PAGE result
Interleukin-1 +¦, Interleukin-1 beta, IL-1+¦, IL1F2, IL-1BETA, IL-1B, IL1B, IL-1 +¦/IL-1F2, IL-1 +¦, IL-1 beta

IL-1 beta/IL-1F2 Protein, Feline, Recombinant
RHC-CGF-0344
17.5 kDa (predicted)
interleukin 1, +¦, interleukin 1, beta, IL-1 +¦

IL-1 beta/IL-1F2 Protein, Human, Recombinant
RHC-CGF-0091
17 kDa (predicted); 17 kDa (reducing conditions)
interleukin 1, +¦, interleukin 1, beta, IL1-+¦, IL1F2, IL1-BETA, IL-1B, IL-1 +¦, IL-1 beta, IL-1

IL-1 beta/IL-1F2 Protein, Human, Recombinant (His & Avi)
RHC-CGF-0164
20.1 kDa (predicted) same as Tris-Bis PAGE result.
Interleukin-1 +¦, Interleukin-1 beta, IL-1+¦, IL1F2, IL-1BETA, IL-1B, IL1B, IL-1 +¦/IL-1F2, IL-1 +¦, IL-1 beta

IL-1 beta/IL-1F2 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0370
20.1 kDa (predicted) same as Tris-Bis PAGE result.
Interleukin-1 +¦, Interleukin-1 beta, IL-1+¦, IL1F2, IL-1BETA, IL-1B, IL1B, IL-1 +¦/IL-1F2, IL-1 +¦, IL-1 beta

IL-1 beta/IL-1F2 Protein, Human, Recombinant (His)
RHC-CGF-0171
32.3 kDa (predicted); 34 kDa (reducing conditions)
interleukin 1, +¦, interleukin 1, beta, IL1-+¦, IL1F2, IL1-BETA, IL-1B, IL-1 +¦, IL-1 beta, IL-1

IL-1 beta/IL-1F2 Protein, Mouse, Recombinant
RHC-CGF-0088
17.5 kDa (predicted); 19 kDa (reducing conditions)
interleukin 1, +¦, interleukin 1, beta, IL-1+¦, IL-1beta, Il-1b, IL-1 +¦

IL-1 beta/IL-1F2 Protein, Rabbit, Recombinant
RHC-CGF-0348
17.5 kDa (predicted); 19 kDa (reducing conditions)
interleukin 1, +¦, interleukin 1, beta, IL1-+¦, IL1-BETA, IL1B, IL-1 +¦

IL-1 beta/IL-1F2 Protein, Rat, Recombinant (mature form)
RHC-CGF-0104
17.4 kDa (predicted); 16.92 kDa (reducing conditio
interleukin 1, +¦, interleukin 1, beta, IL-1 +¦

IL-1 beta/IL-1F2 Protein, Rhesus, Recombinant
RHC-CGF-0332
17.5 kDa (predicted); 18 kDa (reducing conditions)
interleukin 1, +¦, interleukin 1, beta, IL-1 +¦

IL-1 beta/IL-1F2 Protein, Sus scrofa (Pig), Recombinant
RHC-CGF-0331
17.7 kDa (predicted)
interleukin 1, +¦, interleukin 1, beta, IL-1 +¦

IL-1 R9 Protein, Human, Recombinant (hFc)
RHC-ENZY-1745
66 kDa (predicted); 80-85 kDa (reducing condition,
TIGIRR-1, interleukin 1 receptor accessory protein-like 2, IL1RAPL-2, IL-1R9, IL1R9

IL-1 R9 Protein, Human, Recombinant (His)
RHC-ENZY-1354
40.7 kDa (predicted); 50-55 kDa (reducing conditio
TIGIRR-1, interleukin 1 receptor accessory protein-like 2, IL1RAPL-2, IL-1R9, IL1R9

IL-1 RECEPTOR TYPE I (HUMAN): FC (HUMAN)
IAR42413333

IL-1 Rrp2/IL-1 R6 Protein, Cynomolgus, Recombinant (His)
RHC-RP-0677
37.1 kDa (predicted). Due to glycosylation, the pr
IL-36R, IL1RRP2, IL1RL2, IL-1 Rrp2, IL-1 R6

IL-1 Rrp2/IL-1 R6 Protein, Human, Recombinant (His & Avi)
RHC-RP-0843
39.1 kDa (predicted). Due to glycosylation, the pr
IL-36R, IL1RRP2, IL1RL2, IL-1 Rrp2, IL-1 R6

IL-1 Rrp2/IL-1 R6 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-0682
39.1 kDa (predicted). Due to glycosylation, the pr
IL-36R, IL1RRP2, IL1RL2, IL-1 Rrp2, IL-1 R6

IL-10 HUMAN
IAR4248648

IL-10 Monoclonal Antibody (12G8), Biotin-Conjugate
BR00000277

IL-10 Monoclonal Antibody (945A1A926C2), Biotin-Conjugate
BR00000386

IL-10 Monoclonal Antibody (945A5A10), Biotin-Conjugate
BR00000663

IL-10 Monoclonal Antibody (JES3-12G8), Biotin-Conjugate
BR00000081

IL-10 Monoclonal Antibody (JES5-16E3), Biotin-Conjugate
BR00000183

IL-10 Monoclonal Antibody (JES5-2A5), Biotin-Conjugate
BR00000289

IL-10 Polyclonal Antibody, Biotin-Conjugate
BR00000418

IL-10 Protein, Feline, Recombinant
RHC-CGF-0210
18.9 kDa (predicted); 19 kDa (reducing conditions)
interleukin 10

IL-10 Protein, Human, Recombinant
RHC-CGF-0099
18.6 kDa (predicted); 18 kDa (reducing conditions)
TGIF, Interleukin-10, interleukin 10, IL10A, IL-10, GVHDS, CSIF

IL-10 Protein, Human, Recombinant (His & Avi)
RHC-CGF-0366
21.3 kDa (predicted). Due to glycosylation, the pr
TGIF, MGC126451, MGC126450, Interleukin-10, IL10A, IL-10, GVHDS, CSIF, B-TCGF

IL-10 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0313
21.3 kDa (predicted). Due to glycosylation, the pr
TGIF, MGC126451, MGC126450, Interleukin-10, IL10A, IL-10, GVHDS, CSIF, B-TCGF

IL-10 Protein, Human, Recombinant (His)
RHC-CGF-0250
20.9 kDa (predicted); 20.9 kDa (reducing condition
TGIF, Interleukin-10, interleukin 10, IL10A, IL-10, GVHDS, CSIF

IL-10 Protein, Mouse, Recombinant
RHC-CGF-0103
18.9 kDa (predicted)
interleukin 10, Il-10, CSIF

IL-10 Protein, Rat, Recombinant
RHC-CGF-0219
18.6 kDa (predicted); 18 kDa (reducing conditions)
interleukin 10

IL-10 Protein, Sus scrofa (Pig), Recombinant
RHC-CGF-0233
18.2 kDa (predicted); 18 kDa (reducing conditions)
interleukin 10

IL-10 Rabbit Monoclonal Antibody (128), Biotin-Conjugate Recombinant
BR00000969

IL-10R alpha/IL-10RA Protein, Cynomolgus, Recombinant (His)
RHC-RP-0717
25.34 kDa (predicted). Due to glycosylation, the p
IL-10RA, IL10RA, IL-10R1, IL-10R subunit 1, IL10R, IL-10 R +¦, IL-10 R alpha, IBD28, HIL-10R, CDw210a

IL-10R alpha/IL-10RA Protein, Human, Recombinant (His & Avi)
RHC-RP-0664
27 kDa (predicted). Due to glycosylation, the prot
IL-10RA, IL10RA, IL-10R1, IL-10R subunit 1, IL10R, IL-10 R +¦, IL-10 R alpha, IBD28, HIL-10R, CDw210a

IL-10R alpha/IL-10RA Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-0599
27 kDa (predicted). Due to glycosylation, the prot
IL-10RA, IL10RA, IL-10R1, IL-10R subunit 1, IL10R, IL-10 R +¦, IL-10 R alpha, IBD28, HIL-10R, CDw210a

IL-10R alpha/IL-10RA Protein, Human, Recombinant (His)
RHC-RP-0595
25.8 kDa (predicted)
interleukin 10 receptor, +¦, interleukin 10 receptor, alpha, IL-10R1, IL10R, HIL-10R, CDW210A, CD210a, CD210

IL-10R alpha/IL-10RA Protein, Macaca mulatta, Recombinant (His)
RHC-RP-0798
35-55 kDa (reducing condition)
Interleukin-10 receptor subunit +¦, Interleukin-10 receptor subunit alpha, Interleukin-10 receptor subunit 1, IL-10RA, IL10RA, IL-10R1, IL-10R subunit +¦, IL-10R subunit alpha, IL-10R subunit 1, IL-10 receptor subunit +¦, IL-10 receptor subuni

IL-10R alpha/IL-10RA Protein, Mouse, Recombinant (hFc)
RHC-RP-0724
52.7 kDa (predicted)
mIL-10R, interleukin 10 receptor, +¦, interleukin 10 receptor, alpha, Il10r, CDw210a, CDw210, AW553859

IL-10R alpha/IL-10RA Protein, Rhesus, Recombinant (hFc)
RHC-RP-0616
51.8 kDa (predicted)
interleukin 10 receptor, +¦, interleukin 10 receptor, alpha

IL-10R alpha/IL-10RA Protein, Rhesus, Recombinant (His)
RHC-RP-0673
26.2 kDa (predicted)
interleukin 10 receptor, +¦, interleukin 10 receptor, alpha

IL-10R beta/IL-10RB Protein, Human, Recombinant (hFc)
RHC-RP-0602
75-95 kDa (reducing condition)
Interleukin-10 receptor subunit +¦(IL10RB), Interleukin-10 receptor subunit beta(IL10RB), Interleukin-10 receptor subunit 2, Cytokine receptor family 2 member 4, Cytokine receptor class-II member 4

IL-10R beta/IL-10RB Protein, Human, Recombinant (His & hFc)
RHC-RP-0810
51.7 kDa (predicted); 75-85 kDa (reducing conditio
interleukin 10 receptor, +¦, interleukin 10 receptor, beta, IL-10R2, D21S66, D21S58, CRFB4, CRF2-4, CDW210B

IL-10R beta/IL-10RB Protein, Human, Recombinant (His)
RHC-RP-0766
25 kDa (predicted); 45-48 kDa (reducing condition,
interleukin 10 receptor, +¦, interleukin 10 receptor, beta, IL-10R2, D21S66, D21S58, CRFB4, CRF2-4, CDW210B

IL-10R beta/IL-10RB Protein, Mouse, Recombinant (hFc)
RHC-RP-0653
50.5 kDa (predicted); 65-75 kDa (reducing conditio
interleukin 10 receptor, +¦, interleukin 10 receptor, beta, IL-10R2, Il10r2, D21S58h, D16H21S58, Crfb4, CRF2-4, AI528744, 6620401D04Rik

IL-10R beta/IL-10RB Protein, Mouse, Recombinant (His)
RHC-RP-0575
25 kDa (predicted); 35-45 kDa (reducing condition,
interleukin 10 receptor, +¦, interleukin 10 receptor, beta, IL-10R2, Il10r2, D21S58h, D16H21S58, Crfb4, CRF2-4, AI528744, 6620401D04Rik

IL-10R beta/IL-10RB Protein, Rat, Recombinant (hFc)
RHC-RP-0591
50.7 kDa (predicted); 68 kDa (reducing conditions)
interleukin 10 receptor, +¦, interleukin 10 receptor, beta

IL-11 HUMAN
IAR4248649

IL-11 Polyclonal Antibody, Biotin-Conjugate
BR00000490

IL-11 Protein, Cynomolgus, Recombinant
RHC-CGF-0207
19.39 kDa (predicted)
Interleukin 11

IL-11 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0239
20.48 kDa (predicted). Due to glycosylation, the p
Oprelvekin, Interleukin-11, interleukin 11, INN: Oprelvekin, IL-11Oprelvekin, IL11, AGIF, Adipogenesis inhibitory factor

IL-11 Protein, Human, Recombinant
RHC-CGF-0106
19.1 kDa (predicted); 23 kDa (reducing conditions)
interleukin 11, IL-11, AGIF

IL-11 Protein, Human, Recombinant (His)
RHC-CGF-0260
20.24 kDa (predicted). Due to glycosylation, the p
Oprelvekin, Interleukin-11, interleukin 11, INN: Oprelvekin, IL-11Oprelvekin, IL11, AGIF, Adipogenesis inhibitory factor

IL-11 Protein, Human, Recombinant (P. pastoris)
RHC-CGF-0282
19 kDa (reducing condition)
Oprelvekin, Interleukin-11, IL-11, IL11, AGIF, Adipogenesis Inhibitory Factor

IL-11 Protein, Mouse, Recombinant
RHC-CGF-0123
19.2 kDa (predicted)
interleukin 11, IL-11

IL-11 Protein, Mouse, Recombinant (hFc)
RHC-CGF-0359
50-60 kDa (reducing condition)
Interleukin-11, IL-11, Il11

IL-11 Protein, Rat, Recombinant (His & Myc)
RHC-CGF-0264
26.6 kDa (predicted)
Interleukin-11, Il11

IL-11 Protein, Rat, Recombinant (His & PDI)
RHC-CGF-0252
78.0 kDa (predicted)
Interleukin-11, Il11

IL-11R alpha chain 1/IL-11RA1 Protein, Rat, Recombinant (His)
RHC-RP-0558
39.1 kDa (predicted)
interleukin 11 receptor, +¦ chain 1, interleukin 11 receptor, alpha chain 1, Il11ra1

IL-11R alpha/IL-11RA Protein, Canine, Recombinant
RHC-RP-0831
37.8 kDa (predicted); 43-47 kDa (reducing conditio
interleukin 11 receptor subunit +¦, interleukin 11 receptor subunit alpha, IL11RA

IL-11R alpha/IL-11RA Protein, Canine, Recombinant (hFc)
RHC-RP-0756
64 kDa (predicted)
interleukin 11 receptor subunit +¦, interleukin 11 receptor subunit alpha, IL11RA

IL-11R alpha/IL-11RA Protein, Canine, Recombinant (His)
RHC-RP-0657
38.4 kDa (predicted); 47.7 kDa (reducing condition
interleukin 11 receptor subunit +¦, interleukin 11 receptor subunit alpha, IL11RA

IL-11R alpha/IL-11RA Protein, Human, Recombinant (His)
RHC-RP-0617
38.6 kDa (predicted); 47 kDa (reducing condition,
MGC2146, interleukin 11 receptor subunit +¦, interleukin 11 receptor subunit alpha, IL11RA, hCG_2011440, CRSDA

IL-11R alpha/IL-11RA Protein, Mouse, Recombinant (His)
RHC-RP-0719
39.2 kDa (predicted); 45-50 kDa (reducing conditio
RP23-167I12.2, NR1, interleukin 11 receptor subunit +¦, interleukin 11 receptor subunit alpha, Il11ra2, Il11ra1, Il-11ra, Il11ra, GP130, AI314697

IL-12 (p40/p35) Fc Fusion (lgG1), Avi-Tag, Biotin-Labeled Recombinant
BR00028675
87 k + glycans
Interleukin-12 subunit alpha, IL-12A, CLMF p35, IL-12 subunit p35, NK cell stimulatory factor chain 1, NKSF1, Interleukin-12 subunit beta, IL-12B, CLMF p40, IL-12 subunit p40, NK cell stimulatory factor chain 2, NKSF2

IL-12 FROM MOUSE
IAR4248660

IL-12 FROM RAT
IAR42413343

IL-12 HUMAN
IAR4248650

IL-12 p70 Monoclonal Antibody (A193D11C4), Biotin-Conjugate
BR00001105

IL-12 p70 Monoclonal Antibody (A25C4B6), Biotin-Conjugate
BR00000685

IL-12 p70 Monoclonal Antibody (C17-8), Biotin-Conjugate
BR00000369

IL-12 p70 Polyclonal Antibody, Biotin-Conjugate
BR00000080

IL-12 Protein, Human, Recombinant
RHC-CGF-0125
57.2 kDa (predicted); 34&41 kDa (reducing conditio
P35, NKSF2, NKSF1, NKSF, NFSK, interleukin 12A, IMD29, IMD28, IL-12B, IL-12A, IL12 p70, IL12, CLMF2, CLMF

IL-12 Protein, Human, Recombinant (His)
RHC-CGF-0308
60.13 kDa (predicted)
P35, NKSF2, NKSF1, NKSF, NFSK, interleukin 12A, IMD29, IMD28, IL-12B, IL-12A, IL12 p70, IL12, CLMF2, CLMF

IL-12 Protein, Human, Recombinant (His), Biotinylated
RHC-CGF-0299
60.13 kDa (predicted)
P35, NKSF2, NKSF1, NKSF, NFSK, interleukin 12A, IMD29, IMD28, IL-12B, IL-12A, IL12 p70, IL12, CLMF2, CLMF

IL-12 Protein, Mouse, Recombinant (hFc)
RHC-CGF-0115
111.5 kDa (predicted); 55&75 kDa (reducing conditi
p40, p35, Ll12a, interleukin 12A, Il-12p40, Il12p40, IL-12p35, Il-12b, Il-12a

IL-12 Protein, Mouse, Recombinant (His & hFc)
RHC-CGF-0270
85.9 kDa (predicted); 28&75 kDa (reducing conditio
p40, p35, Ll12a, interleukin 12A, Il-12p40, Il12p40, IL-12p35, Il-12b, Il-12a

IL-12 Protein, Mouse, Recombinant (His)
RHC-CGF-0218
60.3 kDa (predicted); 28&47 kDa (reducing conditio
p40, p35, Ll12a, interleukin 12A, Il-12p40, Il12p40, IL-12p35, Il-12b, Il-12a

IL-12 Protein, Rhesus, Recombinant (His)
RHC-CGF-0220
60.2 kDa (predicted)
interleukin 12A

IL-12/IL-23 p40 Monoclonal Antibody (C17.8), Biotin-Conjugate
BR00000245

IL-12/IL-23 p40 Monoclonal Antibody (C8.6), Biotin-Conjugate
BR00000085

IL-12A Protein, Human, Recombinant (hFc)
RHC-CGF-0174
49.3 kDa (predicted); 65-70 kDa (reducing conditio
P35, NKSF1, NFSK, interleukin 12A, IL-12A, CLMF

IL-12A Protein, Human, Recombinant (His)
RHC-CGF-0305
24 kDa (predicted); 35-40 kDa (reducing condition,
P35, NKSF1, NFSK, interleukin 12A, IL-12A, CLMF

IL-12A Protein, Rhesus, Recombinant (hFc)
RHC-CGF-0329
49.6 kDa (predicted)
interleukin 12A

IL-12B Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0254
35.86 kDa (predicted). Due to glycosylation, the p
NKSF2, NKS, IL-12B, IL-12 subunit p40, CLMF2, CLMF p40, CLMF

IL-12B Protein, Human, Recombinant
RHC-CGF-0156
40-47 kDa (reducing condition)
NKSF2, NK cell stimulatory factor chain 2, Interleukin-12 subunit +¦, Interleukin-12 subunit beta, IL-12B, IL12B, IL-12 subunit p40, Cytotoxic lymphocyte maturation factor 40 kDa subunit, CLMF p40

IL-12B Protein, Human, Recombinant (hFc)
RHC-CGF-0288
61.4 kDa (predicted)
NKSF2, NKSF, interleukin 12B, IMD29, IMD28, IL-12B, IL12 p40, CLMF2, CLMF

IL-12B Protein, Human, Recombinant (His)
RHC-CGF-0216
36.2 kDa (predicted); 40-50 kDa (reducing conditio
NKSF2, NKSF, interleukin 12B, IMD29, IMD28, IL-12B, IL12 p40, CLMF2, CLMF

IL-12B Protein, Marmoset, Recombinant (hFc)
RHC-CGF-0215
61.9 kDa (predicted); 66 kDa (reducing conditions)
interleukin 12B

IL-12B Protein, Mesocricetus auratus, Recombinant (His & Myc)
RHC-CGF-0155
39.8 kDa (predicted)
Interleukin-12 subunit beta, IL12B, IL-12 subunit p40, Cytotoxic lymphocyte maturation factor 40 kDa subunit

IL-12B Protein, Mouse, Recombinant
RHC-CGF-0176
36.6 kDa (predicted); 46 kDa (reducing conditions)
p40, interleukin 12B, Il-12p40, Il12p40, Il-12b

IL-12B Protein, Mouse, Recombinant (hFc)
RHC-CGF-0186
62.8 kDa (predicted); 83 kDa (reducing condition,
p40, interleukin 12B, Il-12p40, Il12p40, Il-12b

IL-12B Protein, Rabbit, Recombinant (His)
RHC-CGF-0320
36.1 kDa (predicted)
interleukin 12B

IL-12B Protein, Rat, Recombinant (hFc)
RHC-CGF-0209
62.5 kDa (predicted)
interleukin 12B

IL-12B Protein, Rat, Recombinant (His)
RHC-CGF-0296
37.2 kDa (predicted); 47 and 45 kDa (reducing cond
interleukin 12B

IL-12P40 HUMAN
IAR4248651

IL-12P80 HUMAN
IAR4248652

IL-12RB1 Protein, Cynomolgus, Recombinant (His)
RHC-CD-2792
58.98 kDa (predicted); 78.33 kDa (reducing conditi
interleukin 12 receptor, +¦1, interleukin 12 receptor, beta 1

IL-12RB1 Protein, Human, Recombinant (His)
RHC-CD-2583
58.5 kDa (predicted); 70 kDa (reducing condition,
interleukin 12 receptor, +¦1, interleukin 12 receptor, beta 1, IMD30, IL-12R-+¦1, IL-12R-BETA1, IL12RB, CD212

IL-12RB2 Protein, Cynomolgus, Recombinant (mFc)
RHC-CD-2793
94.93 kDa (predicted); 111.51 kDa (reducing condit
interleukin 12 receptor, +¦2, interleukin 12 receptor, beta 2

IL-12RB2 Protein, Mouse, Recombinant (His)
RHC-CD-2781
70 kDa (predicted); 120-130 kDa (reducing conditio
interleukin 12 receptor, +¦2, interleukin 12 receptor, beta 2, IL-12RB2, Ifnm, A930027I18Rik

IL-13 FROM RAT
IAR42413351

IL-13 LONG FORM FROM RAT
IAR42413350

IL-13 Monoclonal Antibody (5A2), Biotin-Conjugate
BR00000382

IL-13 Monoclonal Antibody (eBio1316H), Biotin-Conjugate
BR00000230

IL-13 Polyclonal Antibody, Biotin-Conjugate
BR00000404

IL-13 Protein, Canine, Recombinant (His)
RHC-CGF-0229
16.5 kDa (predicted)
Interleukin-13, IL13

IL-13 Protein, Cynomolgus, Recombinant
RHC-CGF-0339
12.3 kDa (predicted); 12.3 kDa (reducing condition
interleukin 13

IL-13 Protein, Equus caballus, Recombinant (His)
RHC-CGF-0243
13.9 kDa (predicted)
Interleukin-13, IL13

IL-13 Protein, Human, Recombinant
RHC-CGF-0093
12.5 kDa (predicted); 12.5 kDa (reducing condition
P600, interleukin 13, IL-13, ALRH

IL-13 Protein, Human, Recombinant (Avi & His), Biotinylated
RHC-CGF-0158
22-35 kDa (reducing condition)
Interleukin-13, IL-13

IL-13 Protein, Human, Recombinant (hFc)
RHC-CGF-0338
39 kDa (predicted); 50-55 kDa (reducing condition,
P600, interleukin 13, IL-13, ALRH

IL-13 Protein, Human, Recombinant (His & Avi)
RHC-CGF-0304
15.3 kDa (predicted). Due to glycosylation, the pr
P600, NC30, MGC116789, MGC116788, MGC116786, interleukin 13, IL-13, IL13, BHR1, ALRH

IL-13 Protein, Human, Recombinant (His)
RHC-CGF-0117
13-30 kDa (reducing condition)
Interleukin-13, IL-13

IL-13 Protein, Human, Recombinant (mFc)
RHC-CGF-0169
38-60 kDa (reducing condition)
Interleukin-13, IL-13

IL-13 Protein, Mouse, Recombinant
RHC-CGF-0097
12.35 kDa (predicted); 14 kDa (reducing conditions
interleukin 13, Il-13

IL-13 Protein, Mouse, Recombinant (aa 22-131, His)
RHC-CGF-0108
14-30 kDa (reducing condition)
T-Cell Activation Protein P600, Interleukin-13, IL-13, Il13

IL-13 Protein, Mouse, Recombinant (aa 26-131, His)
RHC-CGF-0144
15-30 kDa (reducing condition)
T-Cell Activation Protein P600, Interleukin-13, IL-13, Il13

IL-13 VARIANT HUMAN
IAR4248653

IL-13RA1 Protein, Cynomolgus, Recombinant (hFc)
RHC-RP-0662
63.23 kDa (predicted); 86.76 kDa (reducing conditi
interleukin 13 receptor, +¦1, interleukin 13 receptor, alpha 1

IL-13RA1 Protein, Cynomolgus, Recombinant (His)
RHC-RP-0675
37.9 kDa (predicted)
interleukin 13 receptor, +¦1, interleukin 13 receptor, alpha 1

IL-13RA1 Protein, Human, Recombinant (aa 1-343, hFc)
RHC-RP-0742
63.62 kDa (predicted); 81.81 kDa (reducing conditi
NR4, interleukin 13 receptor, +¦1, interleukin 13 receptor, alpha 1, IL-13Ra, CD213A1

IL-13Ra1 Protein, Human, Recombinant (hFc)
RHC-RP-0562
63.4 kDa (predicted). Due to glycosylation, the pr
NR4, IL13RA1, IL13RA, IL13R, IL-13 R +¦1, IL-13 R alpha 1, CT19, CD213A1, AI882074

IL-13RA1 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-0802
39.5 kDa (predicted). Due to glycosylation, the pr
NR4, IL13RA1, IL13RA, IL13R, IL-13 R +¦1, IL-13 R alpha 1, CT19, CD213A1, AI882074

IL-13RA1 Protein, Human, Recombinant (His & hFc)
RHC-RP-0652
65 kDa (predicted); 85-95 kDa (reducing condition,
NR4, interleukin 13 receptor, +¦1, interleukin 13 receptor, alpha 1, IL-13Ra, CD213A1

IL-13RA1 Protein, Human, Recombinant (His)
RHC-RP-0830
38.3 kDa (predicted); 55-65 kDa (reducing conditio
NR4, interleukin 13 receptor, +¦1, interleukin 13 receptor, alpha 1, IL-13Ra, CD213A1

IL-13RA1 Protein, Human, Recombinant(aa 1-343, His & Avi), Biotinylated
RHC-RP-0739
40.15 kDa (predicted); 57.82 kDa (reducing conditi
NR4, interleukin 13 receptor, +¦1, interleukin 13 receptor, alpha 1, IL-13Ra, CD213A1

IL-13RA1 Protein, Mouse, Recombinant (hFc)
RHC-RP-0865
62.8 kDa (predicted)
NR4, interleukin 13 receptor, +¦1, interleukin 13 receptor, alpha 1, Il13ra, IL-13r[a], CD213a1, AI882074

IL-13RA1 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-RP-0598
58-85 kDa (reducing condition)
NR4, Novel cytokine receptor 4, Interleukin-13-binding protein, Interleukin-13 receptor subunit +¦-1, Interleukin-13 receptor subunit alpha-1, IL-13RA1, CD213a1

IL-13RA1 Protein, Mouse, Recombinant (His)
RHC-RP-0696
37.6 kDa (predicted); 50-55 kDa (reducing conditio
NR4, interleukin 13 receptor, +¦1, interleukin 13 receptor, alpha 1, Il13ra, IL-13r[a], CD213a1, AI882074

IL-13RA1 Protein, Mouse, Recombinant (mFc)
RHC-RP-0839
62.41 kDa (predicted)
NR4, interleukin 13 receptor, +¦1, interleukin 13 receptor, alpha 1, Il13ra, IL-13r[a], CD213a1, AI882074

IL-13RA1 Protein, Rat, Recombinant (hFc)
RHC-RP-0754
62.9 kDa (predicted); 91 kDa (reducing conditions)
interleukin 13 receptor, +¦1, interleukin 13 receptor, alpha 1

IL-13RA2 Polyclonal Antibody, Biotin-Conjugate
BR00001979

IL-13RA2 Protein, Canine, Recombinant (hFc)
RHC-RP-0866
64.1 kDa (predicted); 66-72 kDa (reducing conditio
interleukin 13 receptor, +¦2, interleukin 13 receptor, alpha 2

IL-13RA2 Protein, Canine, Recombinant (His)
RHC-RP-0638
38.6 kDa (predicted); 39-46 kDa (reducing conditio
interleukin 13 receptor, +¦2, interleukin 13 receptor, alpha 2

IL-13Ra2 Protein, Human, Recombinant (hFc)
RHC-RP-0665
63.7 kDa (predicted). Due to glycosylation, the pr
IL-13Ra2, IL13RA2, IL-13R subunit +¦-2, IL-13R subunit alpha-2, IL13R, IL13BP, IL-13 R +¦2, IL-13 R alpha 2, CD213a2

IL-13RA2 Protein, Human, Recombinant (His & hFc)
RHC-RP-0695
65 kDa (predicted); 90-100 kDa (reducing condition
interleukin 13 receptor, +¦2, interleukin 13 receptor, alpha 2, IL-13R, IL13BP, CT19, CD213A2

IL-13RA2 Protein, Human, Recombinant (His)
RHC-RP-0808
38 kDa (predicted); 49.7 kDa (reducing condition,
interleukin 13 receptor, +¦2, interleukin 13 receptor, alpha 2, IL-13R, IL13BP, CT19, CD213A2

IL-13RA2 Protein, Human, Recombinant (His), Biotinylated
RHC-RP-0824
38 kDa (predicted)
interleukin 13 receptor, +¦2, interleukin 13 receptor, alpha 2, IL-13R, IL13BP, CT19, CD213A2

IL-13RA2 Protein, Mouse, Recombinant (hFc)
RHC-RP-0786
63.19 kDa (predicted); 86.14 kDa (reducing conditi
interleukin 13 receptor, +¦2, interleukin 13 receptor, alpha 2, CD213a2

IL-13RA2 Protein, Mouse, Recombinant (His & hFc)
RHC-RP-0582
64.5 kDa (predicted); 75-80 kDa (reducing conditio
interleukin 13 receptor, +¦2, interleukin 13 receptor, alpha 2, CD213a2

IL-13RA2 Protein, Mouse, Recombinant (His)
RHC-RP-0567
37.55 kDa (predicted). Due to glycosylation, the p
IL-13Ra2, IL13RA2, IL13R, IL13BP, IL-13 R +¦2, IL-13 R alpha 2, CD213a2

IL-13RA2 Protein, Mouse, Recombinant (mFc)
RHC-RP-0632
62.84 kDa (predicted)
interleukin 13 receptor, +¦2, interleukin 13 receptor, alpha 2, CD213a2

IL-13RA2 Protein, Rat, Recombinant (hFc)
RHC-RP-0735
63.4 kDa (predicted); 89-93 kDa (reducing conditio
interleukin 13 receptor, +¦2, interleukin 13 receptor, alpha 2

IL-13RA2 Protein, Rat, Recombinant (His)
RHC-RP-0718
37.9 kDa (predicted); 44 kDa (reducing condition,
interleukin 13 receptor, +¦2, interleukin 13 receptor, alpha 2

IL-15 & IL-15RA Protein, Human, Recombinant (hFc)
RHC-CGF-0337
47.9 kDa (predicted)

IL-15 & IL-15RA Protein, Mouse, Recombinant (His)
RHC-CGF-0113
34.46 kDa (predicted); 50.02, 23.49, 21.78 and 19.

IL-15 FROM MOUSE
IAR42413353

IL-15 FROM RAT
IAR42413354

IL-15 HUMAN
IAR4248654

IL-15 Polyclonal Antibody, Biotin-Conjugate
BR00000124

IL-15 Protein, Human, Recombinant
RHC-CGF-0148
12.8 kDa (predicted)
interleukin 15, IL-15

IL-15 Protein, Human, Recombinant (His)
RHC-CGF-0346
14.9 kDa (predicted); 15 kDa (reducing conditions)
interleukin 15, IL-15

IL-15 Protein, Rhesus macaque, Recombinant (His)
RHC-CGF-0238
14.9 kDa (predicted)
Interleukin-15, IL15

IL-15RA & IL-15 Protein, Human, Recombinant (hFc)
RHC-CGF-0127
Interleukin-15, IL15RA&IL15 Complex, IL15RA&IL15, IL-15 Receptor +¦ & IL-15 Fusion Protein, IL-15 Receptor alpha & IL-15 Fusion Protein, IL-15, IL15

IL-15RA & IL-15 Protein, Human, Recombinant - PBS Lyophilized (hFc)
RHC-CGF-0364
Interleukin-15, IL15RA&IL15 Complex, IL15RA&IL15, IL-15 Receptor +¦ & IL-15 Fusion Protein, IL-15 Receptor alpha & IL-15 Fusion Protein, IL-15, IL15

IL-15RA Protein, Human, Recombinant (aa 31-205, hFc)
RHC-CD-2726
45.22 kDa (predicted)
interleukin 15 receptor, +¦, interleukin 15 receptor, alpha, CD215

IL-15RA Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-2697
46.92 kDa (predicted); 73.09 kDa (reducing conditi
interleukin 15 receptor, +¦, interleukin 15 receptor, alpha, CD215

IL-15RA Protein, Human, Recombinant (hFc, Human Cells)
RHC-CD-2523
60-75 kDa (reducing condition)
+¦, MGC104179, interleukin-15 receptor subunit +¦, interleukin-15 receptor subunit alpha, interleukin 15 receptor, IL-15R-+¦, IL-15R-alpha, IL-15RA, IL15RA, IL-15 receptor subunit +¦, IL-15 receptor subunit alpha, CD215 antigen, CD215, alpha

IL-15RA Protein, Human, Recombinant (His & Avi)
RHC-CD-2631
21.3 kDa (predicted). Due to glycosylation, the pr
MGC104179, IL-15RA/IL-15 R +¦/CD215, IL-15RA, IL-15 R +¦, IL-15 R alpha, CD215

IL-15RA Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2735
21.3 kDa (predicted). Due to glycosylation, the pr
MGC104179, IL-15RA/IL-15 R +¦/CD215, IL-15RA, IL-15 R +¦, IL-15 R alpha, CD215

IL-15RA Protein, Human, Recombinant (His)
RHC-CD-2696
20.22 kDa (predicted)
interleukin 15 receptor, +¦, interleukin 15 receptor, alpha, CD215

IL-15RA Protein, Mouse, Recombinant (aa 1-205, hFc)
RHC-CD-2542
45.10 kDa (predicted); 65.86 and 35.82 kDa (reduci
interleukin 15 receptor, +¦, interleukin 15 receptor, alpha, IL-15RA, AA690181

IL-15RA Protein, Mouse, Recombinant (hFc, Human Cells)
RHC-CD-2802
60-90 kDa (reducing condition)
sIL-15 receptor subunit +¦, sIL-15 receptor subunit alpha, Interleukin-15 receptor subunit +¦, Interleukin-15 receptor subunit alpha, Il15ra

IL-16 (121AA) HUMAN
IAR4248655

IL-16 FROM MOUSE
IAR42413356

IL-16 HUMAN
IAR4248778

IL-16 Monoclonal Antibody, Biotin-Conjugate
BR00000621

IL-16 Polyclonal Antibody, Biotin-Conjugate
BR00000492

IL-16 Protein, Human, Recombinant
RHC-CGF-0149
16-20 kDa (reducing condition)
Pro-Interleukin-16, Lymphocyte Chemoattractant Factor, LCF, Interleukin-16, IL-16, IL16

IL-16 Protein, Human, Recombinant (His)
RHC-CGF-0204
15.3 kDa (predicted); 24 kDa (reducing conditions)
prIL-16, PRIL16, NIL16, LCF, interleukin 16

IL-16 Protein, Mouse, Recombinant (His)
RHC-CGF-0118
14.5 kDa (predicted); 20 kDa (reducing conditions)
mKIAA4048, interleukin 16

IL-17 HUMAN
IAR42413359

IL-17 Protein, Canine, Recombinant
RHC-CGF-0268
15.2 kDa (predicted); 15 kDa (reducing condition,
interleukin 17A

IL-17 Protein, Marmoset, Recombinant
RHC-CGF-0177
15.4 kDa (predicted); 17 kDa (reducing conditions)
interleukin 17A

IL-17 Protein, Mouse, Recombinant (His)
RHC-CGF-0114
17-26 kDa (reducing condition)
Interleukin-17A, IL-17A, IL17A, IL-17, IL17, Cytotoxic T-Lymphocyte-Associated Antigen 8, CTLA-8, CTLA8

IL-17 Protein, Rabbit, Recombinant
RHC-CGF-0323
15.1 kDa (predicted)
interleukin 17A

IL-17 Protein, Rabbit, Recombinant (His)
RHC-CGF-0272
17.3 kDa (predicted)
interleukin 17A

IL-17 Protein, Rhesus, Recombinant
RHC-CGF-0330
15.1 kDa (predicted)
interleukin 17A

IL-17A & IL-17F Heterodimer Protein, Human, Recombinant (His)
RHC-CGF-0166
31 kDa (predicted)
interleukin 17A, IL-17A, IL-17, IL17, CTLA8

IL-17A & IL-17F Heterodimer Protein, Rhesus, Recombinant (His)
RHC-CGF-0325
32.5 kDa (predicted)
interleukin 17A

IL-17A FROM RAT
IAR42413365

IL-17A Monoclonal Antibody (3.41.2.6.1), Biotin-Conjugate
BR00000457

IL-17A Monoclonal Antibody (4H1524.1), Biotin-Conjugate
BR00001986

IL-17A Monoclonal Antibody (eBio17B7), Biotin-Conjugate
BR00000018

IL-17A Monoclonal Antibody (eBio64DEC17), Biotin-Conjugate
BR00000151

IL-17A Monoclonal Antibody (OTI1E4), Biotin-Conjugate
BR00001855

IL-17A Polyclonal Antibody, Biotin-Conjugate
BR00000409

IL-17A Protein, Cynomolgus, Recombinant
RHC-CGF-0232
15.1 kDa (predicted)
interleukin 17A

IL-17A Protein, Cynomolgus, Recombinant (His & Avi)
RHC-CGF-0192
18.2 kDa (predicted). Due to glycosylation, the pr
interleukin 17A, IL-17CTLA-8, IL17A, IL17, CTLA-8

IL-17A Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0195
15-25 kDa (reducing condition)
Interleukin-17A, IL-17A, IL17A, IL-17, IL17, Cytotoxic T-Lymphocyte-Associated Antigen 8, CTLA-8, CTLA8

IL-17A Protein, Human, Recombinant
RHC-CGF-0102
15.7 kDa (predicted)
interleukin 17A, IL-17A, IL-17, IL17, CTLA-8, CTLA8

IL-17A Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0193
18.2 kDa (predicted). Due to glycosylation, the pr
interleukin 17A, IL-17CTLA-8, IL17A, IL17, CTLA-8

IL-17A Protein, Human, Recombinant (T26A, His)
RHC-CGF-0145
17.2 kDa (predicted); 18.6 and 20.3 kDa (reducing
interleukin 17A, IL-17A, IL-17, IL17, CTLA-8, CTLA8

IL-17A Protein, Human, Recombinant, Biotinylated
RHC-CGF-0271
15.7 kDa (predicted)
interleukin 17A, IL-17A, IL-17, IL17, CTLA-8, CTLA8

IL-17A Protein, Mouse, Recombinant
RHC-CGF-0159
15.5 kDa (predicted); 16 kDa (reducing conditions)
interleukin 17A, IL-17A, IL-17, IL17, CTLA-8, CTLA8

IL-17A Protein, Mouse, Recombinant (His & Avi)
RHC-CGF-0317
18 kDa (predicted). Due to glycosylation, the prot
interleukin 17A, IL-17CTLA-8, IL17A, IL17, CTLA-8

IL-17A Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CGF-0190
18 kDa (predicted). Due to glycosylation, the prot
interleukin 17A, IL-17CTLA-8, IL17A, IL17, CTLA-8

IL-17A Protein, Rat, Recombinant (His)
RHC-CGF-0132
21.0 kDa (predicted)
Interleukin-17A, Il17a, Cytotoxic T-lymphocyte-associated antigen 8

IL-17B HUMAN
IAR42413360

IL-17B Protein, Human, Recombinant (hFc)
RHC-CGF-0162
44.9 kDa (predicted)
ZCYTO7, NIRF, interleukin 17B, IL-20, IL-17B

IL-17B Protein, Mouse, Recombinant (hFc)
RHC-CGF-0180
44.5 kDa (predicted); 57 kDa (reducing conditions)
Zcyto7, interleukin 17B, 1700006N07Rik, 1110006O16Rik

IL-17B Protein, Mouse, Recombinant (His)
RHC-CGF-0314
19.1 kDa (predicted) same as Tris-Bis PAGE result.
ZCYTO7, NIRF, MGC138901, MGC138900, interleukin 20, interleukin 17B, IL20, IL-17B, Cytokine CX1

IL-17C Protein, Human, Recombinant (hFc)
RHC-CGF-0350
46.5 kDa (predicted)
interleukin 17C, IL-17C, CX2

IL-17C Protein, Human, Recombinant (His & Avi)
RHC-CGF-0226
22.6 kDa (predicted). Due to glycosylation, the pr
IL-17CMGC126884, IL-17C, IL17C, Cytokine CX2, CX2

IL-17C Protein, Human, Recombinant (His)
RHC-CGF-0154
19 kDa (reducing condition)
interleukin-17C, interleukin 17C, IL-17CMGC126884, IL-17C, IL17C, Cytokine CX2, CX2

IL-17D HUMAN
IAR42413361

IL-17D Protein, Human, Recombinant
RHC-CGF-0153
20 kDa (reducing condition)
Interleukin-17D, IL-17D, IL17D

IL-17E FROM RAT
IAR42413366

IL-17E HUMAN
IAR42413363

IL-17E Monoclonal Antibody (11K8B1), Biotin-Conjugate
BR00001989

IL-17E MURINE
IAR42413367

IL-17F FROM MOUSE
IAR42413362

IL-17F FROM RAT
IAR42413368

IL-17F HUMAN
IAR42413364

IL-17F Monoclonal Antibody (4H1629.1), Biotin-Conjugate
BR00001985

IL-17F Monoclonal Antibody (4H450.1), Biotin-Conjugate
BR00001988

IL-17F Polyclonal Antibody, Biotin-Conjugate
BR00000481

IL-17F Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0255
19-22 kDa (reducing condition)
Interleukin-17F, IL-17F, IL17F, Cytokine ML-1

IL-17F Protein, Human, Recombinant
RHC-CGF-0281
15 kDa (reducing condition)
Interleukin-17F, IL-17F, IL17F, Cytokine ML-1

IL-17F Protein, Human, Recombinant (aa 31-163)
RHC-CGF-0324
15.1 kDa (predicted); 15 kDa (reducing conditions)
ML-1, ML1, interleukin 17F, IL-17F, CANDF6

IL-17F Protein, Human, Recombinant (aa 31-163, His)
RHC-CGF-0248
17.2 kDa (predicted); 24 kDa (reducing conditions)
ML-1, ML1, interleukin 17F, IL-17F, CANDF6

IL-17F Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0363
17.5 /14.9 kDa (predicted). Due to glycosylation,
ML1, IL-24, IL24, IL-17F, IL17F, Cytokine ML-1, CANDF6

IL-17F Protein, Human, Recombinant (His)
RHC-CGF-0194
19 kDa (reducing condition)
Interleukin-17F, IL-17F, IL17F, Cytokine ML-1

IL-17F Protein, Mouse, Recombinant
RHC-CGF-0213
15.02 kDa (predicted)
interleukin 17F, IL-17F, C87042

IL-17F Protein, Mouse, Recombinant (His & Avi)
RHC-CGF-0126
17.8 kDa (predicted). Due to glycosylation, the pr
ML1, IL-24, IL24, IL-17F, IL17F, Cytokine ML-1, CANDF6

IL-17F Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CGF-0188
17.8 kDa (predicted). Due to glycosylation, the pr
ML1, IL-24, IL24, IL-17F, IL17F, Cytokine ML-1, CANDF6

IL-17F Protein, Mouse, Recombinant (His)
RHC-CGF-0269
16.3 kDa (predicted)
interleukin 17F, IL-17F, C87042

IL-17F Protein, Rat, Recombinant (His)
RHC-CGF-0298
16.4 kDa (predicted)
interleukin 17F

IL-17RA Protein, Human, Recombinant (aa 1-320, His & Avi),Biotinylated
RHC-CD-2591
36.71 kDa (predicted); 59.88 kDa (reducing conditi
interleukin 17 receptor A, IL-17RA, IL17R, hIL-17R, CDw217, CD217, CANDF5

IL-17RA Protein, Human, Recombinant (aa 33-320, hFc & Avi), Biotinylated
RHC-CD-2616
61.8 kDa (predicted). Due to glycosylation, the pr
ILRA, IL-7R-+¦, IL-7R-alpha, IL-7R, IL-17RA, IL-17R +¦/CD217, IL17R, CDw217, CD217, CANDF5

IL-17RA Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-2524
61.99 kDa (predicted); 89.18 kDa (reducing conditi
interleukin 17 receptor A, IL-17RA, IL17R, hIL-17R, CDw217, CD217, CANDF5

IL-17RA Protein, Human, Recombinant (hFc)
RHC-CD-2791
60.2 kDa (predicted)
interleukin 17 receptor A, IL-17RA, IL17R, hIL-17R, CDw217, CD217, CANDF5

IL-17RA Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2731
50-80 kDa (reducing condition)
interleukin 17 receptor A, IL17Rinterleukin-17 receptor A, IL17RA, CD217

IL-17RA Protein, Human, Recombinant (His)
RHC-CD-2740
35 kDa (predicted); 52-60 kDa (reducing condition,
interleukin 17 receptor A, IL-17RA, IL17R, hIL-17R, CDw217, CD217, CANDF5

IL-17RA Protein, Mouse, Recombinant (hFc)
RHC-CD-2683
60.3 kDa (predicted); 67-77 and 118 kDa (reducing
VDw217, interleukin 17 receptor A, Il17r, Cdw217, AW538159

IL-17RA Protein, Mouse, Recombinant (His)
RHC-CD-2720
34.8 kDa (predicted); 55-60 kDa (reducing conditio
VDw217, interleukin 17 receptor A, Il17r, Cdw217, AW538159

IL-17RA Protein, Rat, Recombinant (hFc)
RHC-CD-2762
59.7 kDa (predicted); 68-102 kDa (reducing conditi
interleukin 17 receptor A

IL-17RA Protein, Rat, Recombinant (His)
RHC-CD-2707
34.1 kDa (predicted); 52-58 kDa (reducing conditio
interleukin 17 receptor A

IL-17RA Protein, Rhesus, Recombinant (hFc)
RHC-CD-2748
60.3 kDa (predicted)
interleukin 17 receptor A

IL-17RA Protein, Rhesus, Recombinant (His)
RHC-CD-2729
35.6 kDa (predicted)
interleukin 17 receptor A

IL-17RA:IL-17A[Biotin] Inhibitor Screening Assay Kit
BR00028166

IL-17RA[Biotin]:IL-17A Inhibitor Screening Assay Kit
BR00028189
Interleukin 17, Interleukin 17 receptor, CTLA8, IL17, activity assay kit

IL-17RB Protein, Human, Recombinant (hFc)
RHC-RP-0775
56.9 kDa (predicted); 67 kDa (reducing conditions)
interleukin 17 receptor B, IL17RH1, IL17BR, EVI27, CRL4

IL-17RB Protein, Human, Recombinant (His)
RHC-RP-0773
31.5 kDa (predicted); 41-45 kDa (reducing conditio
interleukin 17 receptor B, IL17RH1, IL17BR, EVI27, CRL4

IL-17RB Protein, Mouse, Recombinant (hFc)
RHC-RP-0620
56.8 kDa (predicted)
interleukin 17 receptor B, IL-17Rh1, IL17RH1, IL-17ER, Il17br, Evi27

IL-17RB Protein, Mouse, Recombinant (His)
RHC-RP-0818
31.3 kDa (predicted); 42 kDa (reducing condition,
interleukin 17 receptor B, IL-17Rh1, IL17RH1, IL-17ER, Il17br, Evi27

IL-17RB Protein, Rhesus, Recombinant (hFc)
RHC-RP-0707
57 kDa (predicted)
interleukin 17 receptor B

IL-17RB Protein, Rhesus, Recombinant (His)
RHC-RP-0861
31.4 kDa (predicted)
interleukin 17 receptor B

IL-17RC Protein, Human, Recombinant (aa 1-454, His)
RHC-RP-0669
49.6 kDa (predicted); 60 kDa (reducing conditions)
UNQ6118/PRO20040/PRO38901, interleukin 17 receptor C, IL17-RL, IL17RL

IL-17Rc Protein, Human, Recombinant (hFc)
RHC-RP-0799
76.2 kDa (predicted). Due to glycosylation, the pr
ZcytoR14, IL-17RL, IL17Rhom, IL-17RC, IL-17 receptor C

IL-17RC Protein, Human, Recombinant(aa 1-454, hFc)
RHC-RP-0771
75.3 kDa (predicted); 100-120 kDa (reducing condit
UNQ6118/PRO20040/PRO38901, interleukin 17 receptor C, IL17-RL, IL17RL

IL-17RD Protein, Canine, Recombinant (hFc)
RHC-RP-0571
58.2 kDa (predicted)
interleukin 17 receptor D

IL-17RD Protein, Canine, Recombinant (His)
RHC-RP-0763
32.6 kDa (predicted); 50.7 kDa (reducing condition
interleukin 17 receptor D

IL-17RD Protein, Human, Recombinant (hFc)
RHC-RP-0789
75-90 kDa (reducing condition)
SEF, interleukin 17 receptor D, IL17RLM, IL17Rhom, IL-17RDIL-17 receptor D, IL-17RD, IL17RD, IL-17 RD

IL-17RD Protein, Human, Recombinant (His)
RHC-RP-0749
33.5 kDa (predicted); 55-60 kDa (reducing conditio
SEF, interleukin 17 receptor D, IL17RLM, IL-17RD, HH18

IL-17RD Protein, Mouse, Recombinant (hFc)
RHC-RP-0600
80-120 kDa (reducing condition)
Sef, mSef, Interleukin-17 receptor-like protein, Interleukin-17 receptor D, Il17rlm, IL-17RD, Il17rd, IL-17 receptor D

IL-17RD Protein, Mouse, Recombinant (His)
RHC-RP-0853
40-65 kDa (reducing condition)
Sef, mSef, Interleukin-17 receptor-like protein, Interleukin-17 receptor D, Il17rlm, IL-17RD, Il17rd, IL-17 receptor D

IL-17RE Protein, Human, Recombinant (hFc)
RHC-RP-0856
60-75 kDa (reducing condition)
interleukin 17 receptor E, IL-17RE, IL17RE, IL-17 receptor E, IL-17 RE

IL-17RE Protein, Mouse, Recombinant (His)
RHC-RP-0716
38-42 kDa (reducing condition)
interleukin 17 receptor E, IL-17RE, IL17RE, IL-17 receptor E, IL-17 RE

IL-18 Polyclonal Antibody, Biotin-Conjugate
BR00002054

IL-18 Protein (Primary Amine Labeling), Human, Recombinant, Biotinylated
RHC-CGF-0274
18.2 kDa (predicted) same as Tris-Bis PAGE result.
Interleukin 1, IL-1g, IL-1F4, IL1F4, IL-18, IL18, IL-1 +¦, IL-1 gamma, IGIF

IL-18 Protein, Canine, Recombinant (His)
RHC-CGF-0257
22.0 kDa (predicted)
Interleukin-18, Interleukin-1 gamma, Interferon gamma-inducing factor, IL18

IL-18 Protein, Human, Recombinant
RHC-CGF-0249
18.2 kDa (predicted)
Interleukin 18, IL-1g, IL1F4, IL-18, IGIF

IL-18 Protein, Human, Recombinant (GST)
RHC-CGF-0309
48.6 kDa (predicted)
Interleukin 18, IL-1g, IL1F4, IL-18, IGIF

IL-18 Protein, Human, Recombinant (His)
RHC-CGF-0301
16 kDa (reducing condition)
MGC12320, Interleukin-18, Interleukin-1 +¦, Interleukin-1 gamma, Interferon +¦-inducing factor, Interferon gamma-inducing factor, IL-1g, IL1F4, IL-18, IL-1 +¦, IL-1 gamma, IFN-+¦-inducing factor, IFN-gamma-inducing factor, Iboctadekin, GIF

IL-18 Protein, Mouse, Recombinant
RHC-CGF-0112
18.2 kDa (predicted); 19 kDa (reducing conditions)
interleukin 18, Il-18, Igif

IL-18 Protein, Mouse, Recombinant (His)
RHC-CGF-0152
20 kDa (reducing condition)
Interleukin-18, Interleukin-1 +¦, Interleukin-1 gamma, Interferon +¦-inducing factor, Interferon gamma-inducing factor, Il18, IL-1 +¦, IL-1 gamma, Igif, IFN-+¦-inducing factor, IFN-gamma-inducing factor

IL-18 Protein, Rhesus, Recombinant (His)
RHC-CGF-0341
23.7 kDa (predicted)
interleukin 18

IL-18BP Protein (Primary Amine Labeling), Cynomolgus, Recombinant (His), Biotinylated
RHC-CGF-0235
21.14 kDa (predicted). Due to glycosylation, the p
Interleukin-18-binding protein, IL-18BP, Igifbp

IL-18BP Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0361
21.14 kDa (predicted). Due to glycosylation, the p
Interleukin-18-binding protein, IL-18BP, Igifbp

IL-18BP Protein, Human, Recombinant (aa 1-192, hFc)
RHC-CGF-0334
44.4 kDa (predicted)
interleukin 18 binding protein, IL18BPa

IL-18BP Protein, Human, Recombinant (hFc)
RHC-CGF-0278
60-75 kDa (reducing condition)
Tadekinig-alfa and IL18BP, Interleukin-18-binding protein

IL-18BP Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0183
20.5 kDa (predicted). Due to glycosylation, the pr
IL-18BPA, IL-18BP, Igifbp

IL-18BP Protein, Human, Recombinant (His)
RHC-CGF-0173
19 kDa (predicted); 40.3 kDa (reducing condition,
interleukin 18 binding protein, IL18BPa

IL-18BP Protein, Mouse, Recombinant (His)
RHC-CGF-0265
19.4 kDa (predicted); 35-50 kDa (reducing conditio
MC54L, interleukin 18 binding protein, IL-18BP, Igifbp

IL-18BPd Protein, Mouse, Recombinant (hFc)
RHC-CGF-0198
60-90 kDa (reducing condition)
Interleukin-18-binding protein, Interleukin 18 Binding Protein Isoform d, Interferon +¦-inducing factor-binding protein, Interferon gamma-inducing factor-binding protein, IL-18 BPd, Igifbp

IL-18R alpha Protein, Canine, Recombinant (hFc)
RHC-CD-1711
62.9 kDa (predicted); 67-77 kDa (reducing conditio
interleukin 18 receptor 1

IL-18R alpha Protein, Canine, Recombinant (His)
RHC-CD-1323
37.3 kDa (predicted)
interleukin 18 receptor 1

IL-18R alpha Protein, Cynomolgus, Recombinant (aa 22-329, His)
RHC-CD-2637
36.45 kDa (predicted). Due to glycosylation, the p
IL1RRP, IL-18Ra, IL18Ra, IL18R1, IL-18 R1, IL-18 R +¦, IL-18 R alpha, IL-1 Rrp, IL-1 R5, CD218a

IL-18R alpha Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-1785
61.1 kDa (predicted); 70-92 kDa (reducing conditio
interleukin 18 receptor 1

IL-18R alpha Protein, Cynomolgus, Recombinant (His)
RHC-CD-1324
35.6 kDa (predicted); 50-56 kDa (reducing conditio
interleukin 18 receptor 1

IL-18R alpha Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-1405
64.30 kDa (predicted); 107.36 kDa (reducing condit
interleukin 18 receptor 1, IL-1Rrp, IL1RRP, IL18RA, CDw218a, CD218a

IL-18R alpha Protein, Human, Recombinant (hFc)
RHC-CD-1458
62.5 kDa (predicted)
interleukin 18 receptor 1, IL-1Rrp, IL1RRP, IL18RA, CDw218a, CD218a

IL-18R alpha Protein, Human, Recombinant (His & Avi)
RHC-CD-2552
38.8 kDa (predicted). Due to glycosylation, the pr
IL1RRP, IL-18Ra, IL18Ra, IL18R1, IL-18 R1, IL-18 R +¦, IL-18 R alpha, IL-1 Rrp, IL-1 R5, CD218a

IL-18R alpha Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2620
38.8 kDa (predicted). Due to glycosylation, the pr
IL1RRP, IL-18Ra, IL18Ra, IL18R1, IL-18 R1, IL-18 R +¦, IL-18 R alpha, IL-1 Rrp, IL-1 R5, CD218a

IL-18R alpha Protein, Human, Recombinant (His)
RHC-CD-1636
37.2 kDa (predicted); 59.8 kDa (reducing condition
interleukin 18 receptor 1, IL-1Rrp, IL1RRP, IL18RA, CDw218a, CD218a

IL-18R alpha Protein, Human, Recombinant (His), Biotinylated
RHC-CD-0623
37.21 kDa (predicted); 56.06 kDa (reducing conditi
interleukin 18 receptor 1, IL-1Rrp, IL1RRP, IL18RA, CDw218a, CD218a

IL-18R alpha Protein, Mouse, Recombinant (His & hFc)
RHC-CD-1771
63.5 kDa (predicted); 95-105 kDa (reducing conditi
interleukin 18 receptor 1, Il1rrp, Il18r+¦, Il18ralpha

IL-18R alpha Protein, Mouse, Recombinant (His)
RHC-CD-1672
36.8 kDa (predicted); 65-75 kDa (reducing conditio
interleukin 18 receptor 1, Il1rrp, Il18r+¦, Il18ralpha

IL-18R alpha Protein, Mouse, Recombinant (mFc)
RHC-CD-1148
61.74 kDa (predicted)
interleukin 18 receptor 1, Il1rrp, Il18r+¦, Il18ralpha

IL-18R alpha Protein, Rat, Recombinant (hFc)
RHC-CD-1556
62.5 kDa (predicted); 105 kDa (reducing condition,
interleukin 18 receptor 1

IL-18R alpha Protein, Rat, Recombinant (His)
RHC-CD-1788
36.9 kDa (predicted); 54-64 kDa (reducing conditio
interleukin 18 receptor 1

IL-18R beta/IL-18RAP Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-1446
67.04 kDa (predicted); 88.8 kDa (reducing conditio
interleukin 18 receptor accessory protein, IL-1RAcPL, IL-1R-7, IL-1R7, IL-18R-+¦, IL-18R+¦, IL-18R-beta, IL-18Rbeta, IL18RB, IL-18RAcP, IL-18R +¦/IL-18RAP, CDw218b, CD218b, ACPL

IL-18R beta/IL-18RAP Protein, Human, Recombinant (hFc)
RHC-CD-1635
65.2 kDa (predicted); 80-90 kDa (reducing conditio
interleukin 18 receptor accessory protein, IL-1RAcPL, IL-1R-7, IL-1R7, IL-18R-+¦, IL-18R+¦, IL-18R-beta, IL-18Rbeta, IL18RB, IL-18RAcP, IL-18R +¦/IL-18RAP, CDw218b, CD218b, ACPL

IL-18R beta/IL-18RAP Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-0784
41.76 kDa (predicted); 51.1 kDa (reducing conditio
interleukin 18 receptor accessory protein, IL-1RAcPL, IL-1R-7, IL-1R7, IL-18R-+¦, IL-18R+¦, IL-18R-beta, IL-18Rbeta, IL18RB, IL-18RAcP, IL-18R +¦/IL-18RAP, CDw218b, CD218b, ACPL

IL-18R beta/IL-18RAP Protein, Human, Recombinant (His)
RHC-CD-1336
40 kDa (predicted); 50-55 kDa (reducing condition,
interleukin 18 receptor accessory protein, IL-1RAcPL, IL-1R-7, IL-1R7, IL-18R-+¦, IL-18R+¦, IL-18R-beta, IL-18Rbeta, IL18RB, IL-18RAcP, IL-18R +¦/IL-18RAP, CDw218b, CD218b, ACPL

IL-18R beta/IL-18RAP Protein, Mouse, Recombinant (His)
RHC-CD-1773
40.1 kDa (predicted); 44 kDa (reducing conditions)
interleukin 18 receptor accessory protein, IL-1RAcPL, IL-18R-+¦, IL-18R+¦, IL-18R-beta, IL-18Rbeta, IL-18RAcP, IL-18R +¦/IL-18RAP, AcPL

IL-18R beta/IL-18RAP Protein, Rabbit, Recombinant (His)
RHC-CD-1411
40.22 kDa (predicted); 45.31 kDa (reducing conditi
interleukin 18 receptor accessory protein, IL-18R +¦/IL-18RAP

IL-18R beta/IL-18RAP Protein, Rat, Recombinant (His)
RHC-CD-1407
40.28 kDa (predicted); 53.72 kDa (reducing conditi
interleukin 18 receptor accessory protein, IL-18R +¦/IL-18RAP

IL-18R beta/IL-18RAP Protein, Rhesus, Recombinant (hFc)
RHC-CD-1456
65.4 kDa (predicted)
interleukin 18 receptor accessory protein, IL-18R +¦/IL-18RAP

IL-18R beta/IL-18RAP Protein, Rhesus, Recombinant (His)
RHC-CD-1565
39.85 kDa (predicted)
interleukin 18 receptor accessory protein, IL-18R +¦/IL-18RAP

IL-18RAP Protein, Cynomolgus, Recombinant (His)
RHC-CD-1449
39.5 kDa (predicted). Due to glycosylation, the pr
IL-1RAcPL, IL-1R-7, IL-1R7, IL-18R-+¦, IL-18R+¦, IL-18R-beta, IL-18Rbeta, IL18RB, IL18RAP, IL-18RAcP, CDw218b, CD218b, ACPL

IL-18RAP Protein, Human, Recombinant (hFc & His)
RHC-CD-1534
88 kDa (reducing condition)
Interleukin-18 receptor +¦, Interleukin-18 receptor beta, Interleukin-18 receptor accessory protein-like, Interleukin-18 receptor accessory protein, Interleukin-1 receptor 7, IL-1R accessory protein-like, IL18RAP, CDw218b, CD218 antigen-like

IL-19 FROM MOUSE
IAR42413373

IL-19 HUMAN
IAR42413372

IL-19 Polyclonal Antibody, Biotin-Conjugate
BR00000527

IL-19 Protein, Human, Recombinant (hFc)
RHC-CGF-0285
44.6 kDa (predicted). Due to glycosylation, the pr
ZMDA1, NG.1, MDA1, Interleukin-19, IL-19, IL-10C

IL-19 Protein, Human, Recombinant (His)
RHC-CGF-0319
19.2 kDa (predicted)
ZMDA1, NG.1, MDA1, Interleukin-19, interleukin 19, IL-10C

IL-1BETA(208-240)(HUMAN)
CAS:130587-39-2
Formula: C₁₉₁H₂₉₂N₄₈O₅₁S
ACM130587392

IL-1F10 Protein, Human, Recombinant
RHC-CGF-0358
17 kDa (reducing condition)
Interleukin-1 ++, Interleukin-1 Theta, Interleukin-1 HY2, Interleukin-1 Family Member 10, IL-1HY2, IL1HY2, IL-1F10, IL1F10, IL-1 ++, IL-1 Theta, FIL1T, FIL1 ++, FIL1 Theta

IL-1F10 Protein, Human, Recombinant (His)
RHC-CGF-0310
18.4 kDa (predicted)
interleukin 1 family, member 10 (++), interleukin 1 family, member 10 (theta), IL-38, IL1-++, IL1-theta, IL-1HY2, IL1HY2, FKSG75, FIL1-++, FIL1-theta

IL-1F10 Protein, Mouse, Recombinant (His & SUMO)
RHC-CGF-0203
33.1 kDa (predicted)
Interleukin-1 family member 10, Il1f10

IL-1F8 Protein, Human, Recombinant
RHC-CGF-0321
17.7 kDa (predicted); 18 kDa (reducing conditions)
interleukin 36, +¦, interleukin 36, beta, IL36B, IL-1H2, IL1H2, IL-1F8, IL1F8, IL1-ETA, FILI-(ETA), FIL1H, FIL1-(ETA), FIL1

IL-1F8 Protein, Human, Recombinant (His)
RHC-CGF-0247
19.3 kDa (predicted); 20 kDa (reducing conditions)
interleukin 36, +¦, interleukin 36, beta, IL36B, IL-1H2, IL1H2, IL-1F8, IL1F8, IL1-ETA, FILI-(ETA), FIL1H, FIL1-(ETA), FIL1

IL-1F8 Protein, Mouse, Recombinant
RHC-CGF-0307
21 kDa (predicted); 21 kDa (reducing conditions)
RP23-176J12.1, interleukin 36, +¦, interleukin 36, beta, Il36b, 2310043N20Rik

IL-1R ANTAGONIST - CAS 566914-00-9
CAS:566914-00-9
AP566914009
302.41

IL-1R1 Protein, Cynomolgus, Recombinant (hFc)
RHC-ENZY-1744
62.9 kDa (predicted); 73-93 kDa (reducing conditio
interleukin 1 receptor, type I

IL-1R1 Protein, Cynomolgus, Recombinant (His)
RHC-ENZY-1943
37.4 kDa (predicted); 47-57 kDa (reducing conditio
interleukin 1 receptor, type I

IL-1R1 Protein, Human, Recombinant
RHC-ENZY-1367
36.8 kDa (predicted); 56 kDa (reducing conditions)
P80, interleukin 1 receptor, type I, IL-1R-+¦, IL-1R-alpha, IL1RA, IL-1R1, IL1R, IL-1 RI, D2S1473, CD121A

IL-1R1 Protein, Human, Recombinant (hFc)
RHC-ENZY-1950
63 kDa (predicted); 80-90 kDa (reducing condition,
P80, interleukin 1 receptor, type I, IL-1R-+¦, IL-1R-alpha, IL1RA, IL-1R1, IL1R, IL-1 RI, D2S1473, CD121A

IL-1R1 Protein, Human, Recombinant (His)
RHC-ENZY-1524
37.6 kDa (predicted); 51-57 kDa (reducing conditio
P80, interleukin 1 receptor, type I, IL-1R-+¦, IL-1R-alpha, IL1RA, IL-1R1, IL1R, IL-1 RI, D2S1473, CD121A

IL-1R1 Protein, Mouse, Recombinant (hFc)
RHC-ENZY-1795
64.3 kDa (predicted); 70 kDa (reducing condition,
interleukin 1 receptor, type I, IL-iR, Il1r-1, IL-1R1, CD121b, CD121a

IL-1R1 Protein, Mouse, Recombinant (His)
RHC-ENZY-1794
38.7 kDa (predicted); 55-60 kDa (reducing conditio
interleukin 1 receptor, type I, IL-iR, Il1r-1, IL-1R1, CD121b, CD121a

IL-1R1 Protein, Rat, Recombinant (His & mFc)
RHC-ENZY-1909
64.6 kDa (predicted); 90-95 kDa (reducing conditio
interleukin 1 receptor, type I

IL-1R1 Protein, Rat, Recombinant (His)
RHC-ENZY-1713
38.5 kDa (predicted); 50-60 kDa (reducing conditio
interleukin 1 receptor, type I

IL-1R2 Protein, Canine, Recombinant (hFc)
RHC-CD-2593
64.8 kDa (predicted); 65-70 kDa (reducing conditio
interleukin 1 receptor, type II

IL-1R2 Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-2764
64.7 kDa (predicted); 75-89 kDa (reducing conditio
interleukin 1 receptor, type II

IL-1R2 Protein, Human, Recombinant
RHC-CD-2746
38.4 kDa (predicted); 49 kDa (reducing conditions)
interleukin 1 receptor, type II, IL-1RT-2, IL-1RT2, IL1RB, IL1R2c, IL-1R-2, CDw121b, CD121b

IL-1R2 Protein, Human, Recombinant (hFc)
RHC-CD-2655
64.5 kDa (predicted); 70-75 kDa (reducing conditio
interleukin 1 receptor, type II, IL-1RT-2, IL-1RT2, IL1RB, IL1R2c, IL-1R-2, CDw121b, CD121b

IL-1R2 Protein, Human, Recombinant (His)
RHC-CD-2686
39.2 kDa (predicted); 50-55 kDa (reducing conditio
interleukin 1 receptor, type II, IL-1RT-2, IL-1RT2, IL1RB, IL1R2c, IL-1R-2, CDw121b, CD121b

IL-1R2 Protein, Mouse, Recombinant (hFc)
RHC-CD-2687
65.1 kDa (predicted); 91 kDa (reducing condition,
interleukin 1 receptor, type II, Il1r-2, CD121b

IL-1R2 Protein, Mouse, Recombinant (His)
RHC-CD-2526
39.6 kDa (predicted); 56 kDa (reducing condition,
interleukin 1 receptor, type II, Il1r-2, CD121b

IL-1R2 Protein, Rat, Recombinant (His)
RHC-CD-2560
39.7 kDa (predicted); 55-60 kDa (reducing conditio
interleukin 1 receptor, type II

IL-1RA MURINE
IAR42413332

IL-1RA Protein, Cynomolgus, Recombinant (His)
RHC-RP-0659
18.63 kDa (predicted)
INTERLEUKIN 1 RECEPTOR ANTAGONIST

IL-1RA Protein, Human, Recombinant
RHC-RP-0560
17.3 kDa (predicted); 17.3 kDa (reducing condition
MVCD4, IRAP, interleukin 1 receptor antagonist, IL-1RN, IL-1ra3, IL-1ra, IL1RA, IL1F3, ICIL-1RA, DIRA

IL-1RA Protein, Human, Recombinant (hFc)
RHC-RP-0714
43.8 kDa (predicted); 45-55 kDa (reducing conditio
MVCD4, IRAP, interleukin 1 receptor antagonist, IL-1RN, IL-1ra3, IL-1ra, IL1RA, IL1F3, ICIL-1RA, DIRA

IL-1RA Protein, Mouse, Recombinant
RHC-RP-0747
16 kDa (reducing condition)
IRAP, Interleukin-1 Receptor Antagonist Protein, IL-1RN, Il1rn, IL-1ra, IL1 inhibitor

IL-1RA Protein, Rat, Recombinant (hFc)
RHC-RP-0869
45.8 kDa (predicted); 47 kDa (reducing condition,
INTERLEUKIN 1 RECEPTOR ANTAGONIST

IL-1RA Protein, Rat, Recombinant (His)
RHC-RP-0873
19.01 kDa (predicted)
INTERLEUKIN 1 RECEPTOR ANTAGONIST

IL-1RAcP / IL-1 R3 Protein (Cynomolgus, HEK293, His-tag)
NZs001735
IL1RAP

IL-1RAP/IL-1RAcP Protein, Cynomolgus, Recombinant (aa 21-362, His)
RHC-RP-0793
40.49 kDa (predicted). Due to glycosylation, the p
IL-1RAP, IL1RAP, IL-1 RAcP, IL-1 R3, C3orf13

IL-1RAP/IL-1RAcP Protein, Cynomolgus, Recombinant (hFc)
RHC-RP-0725
65.84 kDa (predicted)
interleukin 1 receptor accessory protein

IL-1RAP/IL-1RAcP Protein, Cynomolgus, Recombinant (His)
RHC-RP-0658
40.56 kDa (predicted)
interleukin 1 receptor accessory protein

IL-1RAP/IL-1RAcP Protein, Human, Recombinant (aa 21-356, His)
RHC-RP-0689
50-70 kDa (reducing condition)
Interleukin-1 Receptor Accessory Protein, Interleukin-1 Receptor 3, IL1RAP, IL-1RAcP, IL-1R-3, IL-1R3, IL1R3, IL-1 Receptor Accessory Protein, C3orf13

IL-1RAP/IL-1RAcP Protein, Human, Recombinant (aa 21-359, His & Avi), Biotinylated
RHC-RP-0847
42 kDa (predicted). Due to glycosylation, the prot
IL-1RAP, IL1RAP, IL-1 RAcP, IL-1 R3, C3orf13

IL-1RAP/IL-1RAcP Protein, Human, Recombinant (hFc & His)
RHC-RP-0855
80-100 kDa (reducing condition)
Interleukin-1 Receptor Accessory Protein, Interleukin-1 Receptor 3, IL1RAP, IL-1RAcP, IL-1R-3, IL-1R3, IL1R3, IL-1 Receptor Accessory Protein, C3orf13

IL-1RAP/IL-1RAcP Protein, Human, Recombinant (hFc)
RHC-RP-0823
65.8 kDa (predicted)
interleukin 1 receptor accessory protein, IL-1RAcP, IL1R3, C3orf13

IL-1RAP/IL-1RAcP Protein, Human, Recombinant (His & Avi)
RHC-RP-0842
42 kDa (predicted). Due to glycosylation, the prot
IL-1RAP, IL1RAP, IL-1 RAcP, IL-1 R3, C3orf13

IL-1RAP/IL-1RAcP Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-0760
42.4 kDa (predicted)
interleukin 1 receptor accessory protein, IL-1RAcP, IL1R3, C3orf13

IL-1RAP/IL-1RAcP Protein, Human, Recombinant (His)
RHC-RP-0772
40.7 kDa (predicted); 50-55 kDa (reducing conditio
interleukin 1 receptor accessory protein, IL-1RAcP, IL1R3, C3orf13

IL-1RAP/IL-1RAcP Protein, Mouse, Recombinant (aa 21-367, His)
RHC-RP-0663
41.1 kDa (predicted). Due to glycosylation, the pr
IL1RAP, IL-1 RAcP, IL-1 R3, C3orf13

IL-1RAP/IL-1RAcP Protein, Mouse, Recombinant (hFc)
RHC-RP-0655
65 kDa (predicted); 79.1 kDa (reducing conditions)
interleukin 1 receptor accessory protein, IL-1RAcP, AV239853, AI255955, 6430709H04Rik

IL-1RAP/IL-1RAcP Protein, Mouse, Recombinant (His)
RHC-RP-0737
39.7 kDa (predicted); 53.1 kDa (reducing condition
interleukin 1 receptor accessory protein, IL-1RAcP, AV239853, AI255955, 6430709H04Rik

IL-1RAP/IL-1RAcP Protein, Rat, Recombinant (His & Myc)
RHC-RP-0844
47.5 kDa (predicted)
Interleukin-1 receptor accessory protein, Il1rap

IL-1RAPL1 Protein, Human, Recombinant (hFc)
RHC-ENZY-1931
65 kDa (predicted); 80-85 kDa (reducing condition,
TIGIRR-2, OPHN4, MRX34, MRX21, MRX10, interleukin 1 receptor accessory protein-like 1, IL1RAPL, IL1R8

IL-1RAPL1 Protein, Human, Recombinant (His)
RHC-ENZY-2303
40 kDa (predicted); 50-55 kDa (reducing condition,
TIGIRR-2, OPHN4, MRX34, MRX21, MRX10, interleukin 1 receptor accessory protein-like 1, IL1RAPL, IL1R8

IL-1RL2 Protein, Human, Recombinant (hFc)
RHC-RP-0862
63.2 kDa (predicted)
interleukin 1 receptor like 2, IL-36R, IL1R-rp2, IL-1Rrp2, IL1RRP2

IL-1RL2 Protein, Human, Recombinant (His)
RHC-RP-0736
37.6 kDa (predicted)
interleukin 1 receptor like 2, IL-36R, IL1R-rp2, IL-1Rrp2, IL1RRP2

IL-1RL2 Protein, Mouse, Recombinant (hFc)
RHC-RP-0680
85-120 kDa (reducing condition)
Interleukin-1 receptor-like 2, IL-36R, IL-36 receptor, IL1R-rp2, IL-1Rrp2, IL1RL2

IL-1RL2 Protein, Mouse, Recombinant (His)
RHC-RP-0841
50-70 kDa (reducing condition)
Interleukin-1 receptor-like 2, IL-36R, IL-36 receptor, IL1R-rp2, IL-1Rrp2, IL1RL2

IL-2 (HUMAN): FC (HUMAN)
IAR42413378

IL-2 FROM RAT
IAR4248758

IL-2 HUMAN
IAR4248755

IL-2 Monoclonal Antibody (1A12), Biotin-Conjugate
BR00000374

IL-2 Monoclonal Antibody (B-G5), Biotin-Conjugate
BR00000378

IL-2 Monoclonal Antibody (JES6-5H4), Biotin-Conjugate
BR00000031

IL-2 Monoclonal Antibody, Biotin-Conjugate
BR00000638

IL-2 Polyclonal Antibody, Biotin-Conjugate
BR00000420

IL-2 Protein, Human, Recombinant
RHC-CGF-0120
15.4 kDa (predicted); 18.52 kDa (reducing conditio
TCGF, lymphokine, Interleukin-2, interleukin 2, IL-2

IL-2 Protein, Human, Recombinant (E. coli)
RHC-CGF-0109
TCGF, T-Cell Growth Factor, Interleukin-2, IL-2, IL2, Aldesleukin

IL-2 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0365
16-18 kDa (reducing condition)
TCGF, T-Cell Growth Factor, Interleukin-2, IL-2, IL2, Aldesleukin

IL-2 Protein, Mouse, Recombinant
RHC-CGF-0368
17.4 kDa (predicted); 19 kDa (reducing conditions)
interleukin 2, Il-2

IL-2 Protein, Mouse, Recombinant (His & Avi)
RHC-CGF-0303
20.1 kDa (predicted). Due to glycosylation, the pr
TCGF, T-cell growth factor, IL2, Aldesleukin

IL-2 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CGF-0228
20.1 kDa (predicted). Due to glycosylation, the pr
TCGF, T-cell growth factor, IL2, Aldesleukin

IL-2 Protein, Rabbit, Recombinant (His)
RHC-CGF-0244
19.1 kDa (predicted)
T-cell growth factor, Interleukin-2, IL2

IL-2 Protein, Rat, Recombinant
RHC-CGF-0342
15.6 kDa (predicted); 15 kDa (reducing conditions)
INTERLEUKIN 2

IL-2 Protein, Rat, Recombinant (His)
RHC-CGF-0151
14-16 kDa (reducing condition)
TCGF, T-Cell Growth Factor, Interleukin-2, IL-2, IL2, Aldesleukin

IL-2 Protein, Rhesus macaque, Recombinant (His & Myc & SUMO)
RHC-CGF-0289
35.5 kDa (predicted)
T-cell growth factor, Interleukin-2, IL2

IL-2 R alpha/CD25 Protein, Human, Recombinant (His & Avi)
RHC-CD-0039
24.6 kDa (predicted). Due to glycosylation, the pr
TCGFR, p55, IL2RA, IL2R, IL-2 R +¦/CD25, IL-2 R +¦, IL-2 R alpha, IDDM10, CD25

IL-2 R alpha/CD25 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0111
24.6 kDa (predicted). Due to glycosylation, the pr
TCGFR, p55, IL2RA, IL2R, IL-2 R +¦/CD25, IL-2 R +¦, IL-2 R alpha, IDDM10, CD25

IL-2 R gamma/CD132 Protein (Primary Amine Labeling), Cynomolgus, Recombinant (His), Biotinylated
RHC-CD-2575
28.2 kDa (predicted). Due to glycosylation, the pr
+¦C, SCIDX1, SCIDX, P64, IMD4, IL2RG, IL-2 R +¦/CD132, IL-2 R +¦, IL-2 R gamma, gammaC, CIDX, CD132

IL-2 R gamma/CD132 Protein, Cynomolgus, Recombinant (His)
RHC-CD-2736
28.2 kDa (predicted). Due to glycosylation, the pr
+¦C, SCIDX1, SCIDX, P64, IMD4, IL2RG, IL-2 R +¦/CD132, IL-2 R +¦, IL-2 R gamma, gammaC, CIDX, CD132

IL-2 R gamma/CD132 Protein, Human, Recombinant (His & Avi)
RHC-CD-2803
39.9 kDa (predicted). Due to glycosylation, the pr
+¦C, SCIDX1, SCIDX, P64, IMD4, IL2RG, IL-2 R +¦/CD132, IL-2 R +¦, IL-2 R gamma, gammaC, CIDX, CD132

IL-2 R gamma/CD132 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2614
39.9 kDa (predicted). Due to glycosylation, the pr
+¦C, SCIDX1, SCIDX, P64, IMD4, IL2RG, IL-2 R +¦/CD132, IL-2 R +¦, IL-2 R gamma, gammaC, CIDX, CD132

IL-2 RECEPTOR HUMAN
IAR42413377

IL-2 Superkine Protein, Human, Recombinant (L100F, R101D, L105V, I106V, I112F)
RHC-CGF-0147
TCGF, T-Cell Growth Factor, Interleukin-2, IL-2, IL2, Aldesleukin

IL-2, Fc Fusion (lgG1), Avi-Tag, Biotin-Labeled
BR00028674
44 k + glycans
Interleukin-2, IL-2, T-cell growth factor, TCGF, Aldesleukin, IL2

IL-20 FROM MOUSE
IAR42413380

IL-20 HUMAN
IAR42413379

IL-20 Polyclonal Antibody, Biotin-Conjugate
BR00000077

IL-20 Protein, Human, Recombinant
RHC-CGF-0231
17.7 kDa (predicted); 18 kDa (reducing conditions)
ZCYTO10, interleukin-20, interleukin 20, IL-20, IL10D

IL-20 Protein, Human, Recombinant (hFc)
RHC-CGF-0312
44.8 kDa (predicted). Due to glycosylation, the pr
Zcyto10, MGC96907, IL-20, IL10D, Cytokine Zcyto10

IL-20 Protein, Human, Recombinant (His)
RHC-CGF-0189
19.4 kDa (predicted). Due to glycosylation, the pr
Zcyto10, MGC96907, IL-20, IL10D, Cytokine Zcyto10

IL-20 Protein, Mouse, Recombinant (hFc)
RHC-CGF-0362
44.9 kDa (predicted). Due to glycosylation, the pr
Zcyto10, MGC96907, IL-20, IL10D, Cytokine Zcyto10

IL-20 Protein, Mouse, Recombinant (His)
RHC-CGF-0131
19.5 kDa (predicted). Due to glycosylation, the pr
Zcyto10, MGC96907, IL-20, IL10D, Cytokine Zcyto10

IL-20 Protein, Rat, Recombinant
RHC-CGF-0251
17.7 kDa (predicted); 17 kDa (reducing condition,
interleukin 20

IL-20RA Protein, Canine, Recombinant (hFc)
RHC-RP-0848
52.9 kDa (predicted)
interleukin 20 receptor, +¦, interleukin 20 receptor, alpha

IL-20RA Protein, Human, Recombinant (hFc)
RHC-RP-0817
52 kDa (predicted)
interleukin 20 receptor, +¦, interleukin 20 receptor, alpha, IL-20R-+¦, IL-20R-alpha, IL-20RA, IL-20R1, CRF2-8

IL-20RA Protein, Human, Recombinant (His)
RHC-RP-0750
26.8 kDa (predicted); 40-45 kDa (reducing conditio
interleukin 20 receptor, +¦, interleukin 20 receptor, alpha, IL-20R-+¦, IL-20R-alpha, IL-20RA, IL-20R1, CRF2-8

IL-20RA Protein, Mouse, Recombinant (hFc)
RHC-RP-0788
52.1 kDa (predicted). Due to glycosylation, the pr
ZcytoR7, IL-20R-+¦, IL-20R-alpha, IL-20RA, IL-20R1, FLJ40993, CRF2-8

IL-20RB Protein, Cynomolgus, Recombinant (hFc)
RHC-RP-0699
49.2 kDa (predicted)
interleukin 20 receptor +¦, interleukin 20 receptor beta

IL-20RB Protein, Cynomolgus, Recombinant (His)
RHC-RP-0833
23.9 kDa (predicted)
interleukin 20 receptor +¦, interleukin 20 receptor beta

IL-20RB Protein, Human, Recombinant (hFc)
RHC-RP-0601
60-85 kDa (reducing condition)
MGC34923, Interleukin-20 receptor subunit +¦, Interleukin-20 receptor subunit beta, interleukin-20 receptor II, IL-20R-+¦, IL-20R-beta, IL-20RB, IL-20R2, IL-20 receptor subunit +¦, IL-20 receptor subunit beta, hCG_2022374, FNDC6, fibronectin t

IL-20RB Protein, Human, Recombinant (His)
RHC-RP-0626
23.9 kDa (predicted)
interleukin 20 receptor +¦, interleukin 20 receptor beta, IL-20R2, FNDC6, DIRS1

IL-20RB Protein, Mouse, Recombinant (His)
RHC-RP-0815
23.8 kDa (predicted)
interleukin 20 receptor +¦, interleukin 20 receptor beta, Il20R2, Gm186, Fndc6, AV228068

IL-20RB Protein, Rat, Recombinant (hFc)
RHC-RP-0592
50.2 kDa (predicted); 61 kDa (reducing conditions)
interleukin 20 receptor +¦, interleukin 20 receptor beta

IL-20RB Protein, Rat, Recombinant (His)
RHC-RP-0765
24.6 kDa (predicted); 32-36 kDa (reducing conditio
interleukin 20 receptor +¦, interleukin 20 receptor beta

IL-21 HUMAN
IAR42413384

IL-21 Monoclonal Antibody (eBio2B2-G20 (2B2-G20)), Biotin-Conjugate
BR00000078

IL-21 Polyclonal Antibody, Biotin-Conjugate
BR00000416

IL-21 Protein, Canine, Recombinant
RHC-CGF-0179
15 kDa (predicted); 15 kDa (reducing conditions)
interleukin 21

IL-21 Protein, Human, Recombinant
RHC-CGF-0217
15.6 kDa (predicted); 17 kDa (reducing conditions)
Za11, interleukin 21, IL-21, CVID11

IL-21 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0181
18.30 kDa (predicted) same as Tris-Bis PAGE result
Za11, Interleukin-21, IL-21, CVID11

IL-21 Protein, Mouse, Recombinant
RHC-CGF-0124
14.3 kDa (predicted); 15 kDa (reducing conditions)
interleukin 21, IL-21

IL-21 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CGF-0367
17.9 kDa (predicted) same as Tris-Bis PAGE result.
Za11, Interleukin-21, IL-21, CVID11

IL-21 Protein, Mouse, Recombinant (His)
RHC-CGF-0275
16 kDa (reducing condition)
Interleukin-21, IL-21, IL21

IL-21 Protein, Rat, Recombinant (His)
RHC-CGF-0347
16.64 kDa (predicted); 20 kDa (reducing conditions
interleukin 21

IL-21R Protein, Cynomolgus, Recombinant (aa 41-254, His)
RHC-RP-0797
25.70 kDa (predicted). Due to glycosylation, the p
NILR, IL-21R, IL-21 receptor, CD360

IL-21R Protein, Cynomolgus, Recombinant (His)
RHC-RP-0752
26.4 kDa (predicted); 44.5 kDa (reducing condition
interleukin 21 receptor

IL-21R Protein, Cynomolgus, Rhesus, Recombinant (hFc)
RHC-RP-0649
52 kDa (predicted)
interleukin 21 receptor

IL-21R Protein, Human, Recombinant (hFc)
RHC-RP-0835
52 kDa (predicted)
NILR, interleukin 21 receptor, CD360

IL-21R Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-0705
28.27 kDa (predicted); 50.0 kDa (reducing conditio
NILR, interleukin 21 receptor, CD360

IL-21R Protein, Human, Recombinant (His)
RHC-RP-0811
26.5 kDa (predicted); 42-46 kDa (reducing conditio
NILR, interleukin 21 receptor, CD360

IL-21R Protein, Mouse, Recombinant (aa 20-236, His)
RHC-RP-0857
34-38 kDa (reducing condition)
Nilr, Interleukin-21 receptor, IL-21R, Il21r, IL-21 receptor

IL-21R Protein, Mouse, Recombinant (hFc)
RHC-RP-0697
51.6 kDa (predicted)
NILR, interleukin 21 receptor

IL-21R Protein, Mouse, Recombinant (His)
RHC-RP-0614
26.3 kDa (predicted)
NILR, interleukin 21 receptor

IL-21R Protein, Rat, Recombinant (His)
RHC-RP-0868
26.5 kDa (predicted); 43-48 kDa (reducing conditio
interleukin 21 receptor

IL-21R Protein, Rat, Recombinant (mFc)
RHC-RP-0738
51.4 kDa (predicted)
interleukin 21 receptor

IL-22 FROM MOUSE
IAR42413389

IL-22 HUMAN
IAR42413388

IL-22 Polyclonal Antibody, Biotin-Conjugate
BR00000385

IL-22 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0262
17.69 kDa (predicted). Due to glycosylation, the p
ZCYTO18, TIFIL-23, TIFa, Interleukin-22, IL-TIF, IL-D110, IL-22, Cytokine Zcyto18

IL-22 Protein, Human, Recombinant
RHC-CGF-0110
16.9 kDa (predicted); 15 kDa (reducing conditions)
zcyto18, TIFIL-23, TIFa, interleukin 22, IL-TIF, ILTIF, IL-D110, IL-22

IL-22 Protein, Human, Recombinant (hIgG2 hFc)
RHC-CGF-0372
50-62 kDa (reducing condition)
Interleukin-22, IL-TIF, IL-22, IL22, IL-10-related T-cell-derived-inducible factor, Cytokine Zcyto18

IL-22 Protein, Human, Recombinant (hIgG4 hFc)
RHC-CGF-0225
50-75 kDa (reducing condition)
Interleukin-22, IL-TIF, IL-22, IL22, IL-10-related T-cell-derived-inducible factor, Cytokine Zcyto18

IL-22 Protein, Human, Recombinant (His)
RHC-CGF-0292
18.1 kDa (predicted)
zcyto18, TIFIL-23, TIFa, interleukin 22, IL-TIF, ILTIF, IL-D110, IL-22

IL-22 Protein, Mouse, Recombinant (E. coli)
RHC-CGF-0286
15 kDa (reducing condition)
Interleukin-22a, Interleukin-22, Iltifa, IL-TIF +¦, IL-TIF Alpha, IL-TIF, Iltif, IL-22a, Il22a, IL-22, Il22, IL-10-Related T-Cell-Derived-Inducible Factor

IL-22 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CGF-0184
19.7 kDa (predicted) same as Tris-Bis PAGE result.
ZCYTO18, TIFIL-23, TIFa, Interleukin-22, IL-TIF, IL-D110, IL-22, Cytokine Zcyto18

IL-22 Protein, Mouse, Recombinant (mFc)
RHC-CGF-0150
50-65 kDa (reducing condition)
Interleukin-22a, Interleukin-22, IL-TIF +¦, IL-TIF alpha, IL-TIF, IL-22a, IL-22, IL22, IL-10-related T-cell-derived-inducible factor

IL-22BP Protein, Human, Recombinant (hFc)
RHC-CGF-0327
55 kDa (predicted)
ZCYTOR16, interleukin 22 receptor, +¦2, interleukin 22 receptor, alpha 2, IL-22R-+¦-2, IL-22R-alpha-2, IL-22RA2, IL-22BP, CRF2X, CRF2-S1, CRF2-10

IL-22BP Protein, Human, Recombinant (Isoform 2, His & hFc)
RHC-CGF-0212
52.8 kDa (predicted); 80-90 kDa (reducing conditio
ZCYTOR16, interleukin 22 receptor, +¦2, interleukin 22 receptor, alpha 2, IL-22R-+¦-2, IL-22R-alpha-2, IL-22RA2, IL-22BP, CRF2X, CRF2-S1, CRF2-10

IL-22BP Protein, Human, Recombinant (Isoform 2, His)
RHC-CGF-0297
26.1 kDa (predicted); 50-55 kDa (reducing conditio
ZCYTOR16, interleukin 22 receptor, +¦2, interleukin 22 receptor, alpha 2, IL-22R-+¦-2, IL-22R-alpha-2, IL-22RA2, IL-22BP, CRF2X, CRF2-S1, CRF2-10

IL-22RA1 Protein, Canine, Recombinant (hFc)
RHC-RP-0779
51.2 kDa (predicted); 56 kDa (reducing conditions)
interleukin 22 receptor, +¦1, interleukin 22 receptor, alpha 1

IL-22RA1 Protein, Canine, Recombinant (His)
RHC-RP-0813
25.6 kDa (predicted); 36 kDa (reducing conditions)
interleukin 22 receptor, +¦1, interleukin 22 receptor, alpha 1

IL-22RA1 Protein, Cynomolgus, Recombinant (His)
RHC-RP-0563
24.84 kDa (predicted). Due to glycosylation, the p
zcytoR11, IL-TIF-R1, IL-22R-+¦-1, IL-22R-alpha-1, IL-22RA1, IL22R1, IL-22R +¦1, IL22R, CRF2-9

IL-22RA1 Protein, Human, Recombinant (hFc)
RHC-RP-0604
51 kDa (predicted). Due to glycosylation, the prot
zcytoR11, IL-TIF-R1, IL-22R-+¦-1, IL-22R-alpha-1, IL-22RA1, IL22R1, IL-22R +¦1, IL22R, CRF2-9

IL-22RA1 Protein, Mouse, Recombinant (hFc)
RHC-RP-0746
51.1 kDa (predicted). Due to glycosylation, the pr
zcytoR11, IL-TIF-R1, IL-22R-+¦-1, IL-22R-alpha-1, IL-22RA1, IL22R1, IL-22R +¦1, IL22R, CRF2-9

IL-22RA1 Protein, Rat, Recombinant (hFc)
RHC-RP-0656
50.8 kDa (predicted)
interleukin 22 receptor, +¦1, interleukin 22 receptor, alpha 1

IL-22RA1 Protein, Rat, Recombinant (His)
RHC-RP-0780
25.5 kDa (predicted)
interleukin 22 receptor, +¦1, interleukin 22 receptor, alpha 1

IL-22RA2 Protein, Human, Recombinant (hFc)
RHC-RP-0597
80-100 kDa (reducing condition)
Interleukin-22-Bind, Interleukin-22 Receptor Subunit +¦-2, Interleukin-22 Receptor Subunit Alpha-2, IL-22R-+¦-2, IL-22R-Alpha-2, IL-22RA2, IL-22 Receptor Subunit +¦-2, IL-22 Receptor Subunit Alpha-2, Cytokine Receptor Family Type 2 Soluble 1,

IL-23 P19/IL23A Protein, Guinea Pig, Recombinant (His & Myc)
RHC-CGF-0287
26.2 kDa (predicted)
Interleukin-23 subunit p19, Interleukin-23 subunit alpha, IL23A

IL-23 P19/IL23A Protein, Human, Recombinant (hFc)
RHC-CGF-0182
45.4 kDa (predicted)
SGRF, P19, interleukin 23, +¦ subunit p19, interleukin 23, alpha subunit p19, IL23P19, IL-23A, IL-23

IL-23 P19/IL23A Protein, Human, Recombinant (mFc)
RHC-CGF-0300
45 kDa (predicted)
SGRF, P19, interleukin 23, +¦ subunit p19, interleukin 23, alpha subunit p19, IL23P19, IL-23A, IL-23

IL-23 P19/IL23A Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CGF-0191
22.60 kDa (predicted). Due to glycosylation, the p
SGRF, P19, Interleukin-23 subunit +¦, Interleukin-23 subunit p19, Interleukin-23 subunit alpha, IL-23p19, IL23p19, IL-23-A, IL23A, IL-23 subunit +¦, IL-23 subunit alpha

IL-23 Protein, Human, Mouse, Recombinant (His)
RHC-CGF-0336
57.3 kDa (predicted)

IL-23 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0161
57.6 kDa (predicted)
SGRF, P19, IL23P19, IL-23A, IL-23, IL23

IL-23 Protein, Human, Recombinant (His)
RHC-CGF-0256
55.8 kDa (predicted); 58.3 kDa (reducing condition
SGRF, P19, IL23P19, IL-23A, IL-23, IL23

IL-23 Protein, Human, Recombinant (His), Biotinylated
RHC-CGF-0136
55.8 kDa (predicted)
SGRF, P19, IL23P19, IL-23A, IL-23, IL23

IL-23 Protein, Marmoset, Recombinant (His)
RHC-CGF-0214
56.4 kDa (predicted); 22&45 kDa (reducing conditio

IL-23 Protein, Mouse, Recombinant (His)
RHC-CGF-0086
58.3 kDa (predicted); 47,45 and 26 kDa (reducing c
p19, IL-23

IL-23 Protein, Rabbit, Recombinant (His)
RHC-CGF-0326
56.6 kDa (predicted)

IL-23 Protein, Rat, Recombinant (His)
RHC-CGF-0253
58.2 kDa (predicted); 47.08, 43.29, 27.67 and 24.7

IL-23R Polyclonal Antibody, Biotin-Conjugate
BR00002635

IL-23R Protein, Canine, Recombinant (His)
RHC-RP-0687
39.31 kDa (predicted). Due to glycosylation, the p
IL-23 receptor, IL-23 R, IBD17

IL-23R Protein, Cynomolgus, Recombinant (His)
RHC-RP-0603
39.03 kDa (predicted). Due to glycosylation, the p
IL-23 receptor, IL-23 R, IBD17

IL-23R Protein, Cynomolgus, Rhesus, Recombinant (hFc)
RHC-RP-0832
64.9 kDa (predicted)
interleukin 23 receptor

IL-23R Protein, Human, Recombinant (aa 24-353, hFc)
RHC-RP-0851
90-120 kDa (reducing condition)
Interleukin-23 receptor, IL-23R, IL23R, IL-23 receptor

IL-23R Protein, Human, Recombinant (aa 24-355, His)
RHC-RP-0685
39.15 kDa (predicted). Due to glycosylation, the p
IL-23 receptor, IL-23 R, IBD17

IL-23R Protein, Human, Recombinant (hFc)
RHC-RP-0863
64.9 kDa (predicted); 92 kDa (reducing condition,
interleukin 23 receptor

IL-23R Protein, Human, Recombinant (His)
RHC-RP-0645
39.3 kDa (predicted)
interleukin 23 receptor

IL-23R Protein, Mouse, Recombinant (hFc)
RHC-RP-0854
90-110 kDa (reducing condition)
Interleukin-23 receptor, interleukin 23 receptor, IL-23R, Il23r, IL-23 receptor

IL-23R Protein, Mouse, Recombinant (His)
RHC-RP-0803
41.48 kDa (predicted). Due to glycosylation, the p
Interleukin-23 receptor, Il23r, IL-23 receptor, IL-23 R, IBD17

IL-23R Protein, Rat, Recombinant (hFc)
RHC-RP-0636
69.4 kDa (predicted)
interleukin 23 receptor

IL-23R Protein, Rat, Recombinant (His)
RHC-RP-0648
43.8 kDa (predicted)
interleukin 23 receptor

IL-23RA:IL-23A[Biotin] Inhibitor Screening Assay Kit
BR00028164

IL-24 Protein, Human, Recombinant (His)
RHC-CGF-0340
19.5 kDa (predicted); 35 kDa (reducing condition,
ST16, MOB5, MDA7, interleukin 24, IL10B, FISP, C49A

IL-24 Protein, Human, Recombinant (mFc)
RHC-CGF-0353
44.6 kDa (predicted)
ST16, MOB5, MDA7, interleukin 24, IL10B, FISP, C49A

IL-25 Polyclonal Antibody, Biotin-Conjugate
BR00000601

IL-25/IL-17E Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0230
19.24 kDa (predicted). Due to glycosylation, the p
interleukin-25, Interleukin-17E, IL-25, IL-17E, IL17E

IL-25/IL17E Protein, Canine, Recombinant (hFc)
RHC-CGF-0356
46.2 kDa (predicted)
interleukin 25

IL-25/IL17E Protein, Human, Recombinant (hFc)
RHC-CGF-0175
45 kDa (predicted); 50-60 kDa (reducing condition,
interleukin 25, IL17E

IL-25/IL17E Protein, Human, Recombinant (His)
RHC-CGF-0167
20-26 kDa (reducing condition)
Interleukin-25, Interleukin-17E, IL-25, IL25, IL-17E, IL17E

IL-25/IL17E Protein, Mouse, Recombinant (His)
RHC-CGF-0107
20 kDa (predicted); 30-35 kDa (reducing condition,
interleukin 25, IL-17e, Il17e

IL-25/IL17E Protein, Rat, Recombinant (hFc)
RHC-CGF-0267
46.1 kDa (predicted); 49 kDa (reducing condition,
interleukin 25

IL-26 Protein, Human, Recombinant (His & Trx)
RHC-CGF-0273
35.8 kDa (predicted)
Protein AK155, Interleukin-26, IL26

IL-26 Protein, Human, Recombinant (His)
RHC-CGF-0185
19.6 kDa (predicted)
Protein AK155, Interleukin-26, IL26

IL-27 Protein, Human, Recombinant (His)
RHC-CGF-0119
56 kDa (predicted); 56 kDa (reducing conditions)
p28, interleukin 27, IL30, IL27p28, IL-27A, IL27A, IL-27

IL-27 Protein, Mouse, Recombinant (His)
RHC-CGF-0105
49.5 kDa (predicted); 60 kDa (reducing condition,
p28, interleukin 27, Il30, IL-27p28, IL-27

IL-27/p28 Polyclonal Antibody, Biotin-Conjugate
BR00002106

IL-27RA/TCCR Protein, Human, Recombinant (His)
RHC-RP-0686
53.55 kDa (predicted). Due to glycosylation, the p
ZcytoR1, WSX-1, WSX1, TCCR, IL-27R-+¦, IL-27R-alpha, IL-27RA, IL27RA, IL27R +¦, IL27R alpha, IL-27 RA, IL27 RA, CRL1

IL-28A Polyclonal Antibody, Biotin-Conjugate
BR00000549

IL-28A Protein, Human, Recombinant (His)
RHC-CGF-0023
21.1 kDa (predicted)
ZCYTO20, interferon, ++2, interferon, lambda 2, IL-28A, IL28A

IL-28A Protein, Mouse, Recombinant (His)
RHC-CGF-0015
21.1 kDa (predicted); 28.5 and 24.7 kDa (reducing
interferon, ++2, interferon, lambda 2, IL-28A, IL28A, Ifnl2, EG330496

IL-28B Protein, Human, Recombinant
RHC-CGF-0080
18 kDa (reducing condition)
ZCYTO22, Interleukin-28C, Interleukin-28B, Interferon ++-4, Interferon ++-3, Interferon Lambda-4, Interferon Lambda-3, IL-28C, IL28C, IL-28B, IL28B, IFN-++-4, IFN-++-3, IFN-Lambda-4, IFN-Lambda-3, IFNL4, IFNL3, Cytokine Zcyto22

IL-28B Protein, Human, Recombinant (His)
RHC-CGF-0050
21 kDa (predicted); 23 kDa (reducing conditions)
interferon, ++3, interferon, lambda 3, IL28C, IL-28B, IL28B

IL-28B Protein, Mouse, Recombinant (His)
RHC-CGF-0081
21.1 kDa (predicted)
interferon, ++3, interferon, lambda 3, INF-++, INF-+¦, INF-lambda, INF-alpha, IL-28B, Il28b, Il28, IFL-1

IL-29 Protein, Human, Recombinant
RHC-CGF-0052
20.2 kDa (predicted)
interferon, ++1, interferon, lambda 1, IL-29, IL29, IFNL1

IL-29 Protein, Human, Recombinant (His)
RHC-CGF-0055
21.4 kDa (predicted); 30-35 kDa (reducing conditio
interferon, ++1, interferon, lambda 1, IL-29, IL29, IFNL1

IL-2R+¦ Antagonist - CAS 1217448-66-2
CAS:1217448-66-2
AP1217448662
446.54 (free base basis)

IL-2RB & IL-2RG Heterodimer Protein, Human, Recombinant (Flag & His)
RHC-RP-0573
54.4 kDa (predicted); 54.6 kDa and 39.3 kDa (reduc

IL-2RG Protein, Human, Recombinant (hFc)
RHC-CD-2706
54.4 kDa (predicted); 71 kDa (reducing conditions)
SCIDX1, SCIDX, P64, interleukin 2 receptor, +¦, interleukin 2 receptor, gamma, IMD4, IL-2RG, CIDX, CD132

IL-2RG Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2612
31.53 kDa (predicted); 60.68 kDa (reducing conditi
SCIDX1, SCIDX, P64, interleukin 2 receptor, +¦, interleukin 2 receptor, gamma, IMD4, IL-2RG, CIDX, CD132

IL-2RG Protein, Human, Recombinant (His)
RHC-CD-2772
29.72 kDa (predicted)
SCIDX1, SCIDX, P64, interleukin 2 receptor, +¦, interleukin 2 receptor, gamma, IMD4, IL-2RG, CIDX, CD132

IL-2RG Protein, Mouse, Recombinant (aa 25-263, hFc)
RHC-CD-2573
80-100 kDa (reducing condition)
Interleukin 2 receptor, +¦ chain, isoform CRA_b, Interleukin 2 receptor, gamma chain, isoform CRA_b, Il2rg

IL-2RG Protein, Mouse, Recombinant (His & hFc)
RHC-CD-2779
56.3 kDa (predicted); 75-85 kDa (reducing conditio
+¦(c), interleukin 2 receptor, +¦, interleukin 2 receptor, gamma, gc, gamma(c), CD132, [g]c

IL-2RG Protein, Mouse, Recombinant (His)
RHC-CD-2651
30 kDa (predicted); 50-55 kDa (reducing condition,
+¦(c), interleukin 2 receptor, +¦, interleukin 2 receptor, gamma, gc, gamma(c), CD132, [g]c

IL-2RG Protein, Mouse, Recombinant(aa 1-263, hFc)
RHC-CD-2776
54.68 kDa (predicted); 78.24 kDa (reducing conditi
+¦(c), interleukin 2 receptor, +¦, interleukin 2 receptor, gamma, gc, gamma(c), CD132, [g]c

IL-2RG Protein, Rat, Recombinant (hFc)
RHC-CD-2594
55 kDa (predicted); 67 kDa (reducing condition, du
interleukin 2 receptor, +¦, interleukin 2 receptor, gamma

IL-2RG Protein, Rat, Recombinant (His)
RHC-CD-2658
29.5 kDa (predicted); 41-50 kDa (reducing conditio
interleukin 2 receptor, +¦, interleukin 2 receptor, gamma

IL-2RG Protein, Rhesus, Recombinant (hFc)
RHC-CD-2794
54.10 kDa (predicted); 84.05 kDa (reducing conditi
interleukin 2 receptor, +¦, interleukin 2 receptor, gamma

IL-2RG Protein, Rhesus, Recombinant (His)
RHC-CD-2646
28.82 kDa (predicted); 49.17 kDa (reducing conditi
interleukin 2 receptor, +¦, interleukin 2 receptor, gamma

IL-3 BETA FROM RAT
IAR42413271

IL-3 beta Polyclonal Antibody, Biotin-Conjugate
BR00000518

IL-3 FROM MOUSE
IAR42413270

IL-3 FROM MOUSE
IAR42413391

IL-3 FROM RAT
IAR42413392

IL-3 HUMAN
IAR42413269

IL-3 HUMAN
IAR42413390

IL-3 Monoclonal Antibody (653A7D6), Biotin-Conjugate
BR00001098

IL-3 Monoclonal Antibody (BVD3-1F9), Biotin-Conjugate
BR00000910

IL-3 Polyclonal Antibody, Biotin-Conjugate
BR00000226

IL-3 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0237
15.13 kDa (predicted) same as Tris-Bis PAGE result
MULTI-CSF, MCGF, interleukin-3, IL-3MGC79398, IL-3, IL3

IL-3 Protein, Human, Recombinant
RHC-CGF-0133
15.2 kDa (predicted)
MULTI-CSF, MCGF, Interleukin-3, interleukin 3, IL-3

IL-3 Protein, Human, Recombinant (hFc)
RHC-CGF-0138
41.6 kDa (predicted). Due to glycosylation, the pr
MULTI-CSF, MCGF, interleukin-3, IL-3MGC79398, IL-3, IL3

IL-3 Protein, Human, Recombinant (His & Avi)
RHC-CGF-0302
16.9 kDa (predicted) same as Tris-Bis PAGE result.
MULTI-CSF, MCGF, interleukin-3, IL-3MGC79398, IL-3, IL3

IL-3 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0236
16.9 kDa (predicted) same as Tris-Bis PAGE result.
MULTI-CSF, MCGF, interleukin-3, IL-3MGC79398, IL-3, IL3

IL-3 Protein, Human, Recombinant (His)
RHC-CGF-0172
16.5 kDa (predicted)
MULTI-CSF, MCGF, Interleukin-3, interleukin 3, IL-3

IL-3 Protein, Mouse, Recombinant
RHC-CGF-0095
15.7 kDa (predicted)
PSF, MCGF, interleukin 3, Il-3, HCGF, Csfmu, BPA

IL-3 Protein, Mouse, Recombinant (hFc)
RHC-CGF-0369
42.2 kDa (predicted). Due to glycosylation, the pr
MULTI-CSF, MCGF, interleukin-3, IL-3MGC79398, IL-3, IL3

IL-3 Protein, Mouse, Recombinant (His)
RHC-CGF-0141
15-32 kDa (reducing condition)
P-cell-stimulating factor, Multipotential colony-stimulating factor, MCGF, Mast cell growth factor, Interleukin-3, IL-3, Il3, Hematopoietic growth factor

IL-31 FROM MOUSE
IAR42413394

IL-31 HUMAN
IAR42413393

IL-31 Polyclonal Antibody, Biotin-Conjugate
BR00000551

IL-31 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0121
16.8 kDa (predicted)
interleukin 31

IL-31 Protein, Human, Recombinant
RHC-CGF-0259
15 kDa (reducing condition)
Interleukin-31, IL-31, IL31

IL-31 Protein, Human, Recombinant (His)
RHC-CGF-0277
17.3 kDa (predicted); 31.8 kDa (reducing condition
interleukin 31, IL-31

IL-31 Protein, Mouse, Recombinant (His)
RHC-CGF-0142
17.1 kDa (predicted)
interleukin 31, 1700013B14Rik

IL-31R alpha Protein, Mouse, Recombinant (His)
RHC-RP-0807
59.2 kDa (predicted)
ZcytoR17, Novel cytokine receptor 10, Interleukin-31 receptor subunit alpha, Il31ra, Gp130-like monocyte receptor, GLM-R

IL-31RA Protein, Human, Recombinant (aa 20-519, hFc)
RHC-RP-0608
83.8 kDa (predicted). Due to glycosylation, the pr
ZcytoR17, PRO21384, IL-31R-+¦, IL-31R-alpha, IL-31RA, GPL, Gp130-like receptor, GLM-RMGC125346, GLM-R, CRL3Glmr, CRL3

IL-31RA Protein, Human, Recombinant (aa 20-519, His)
RHC-RP-0850
58.2 kDa (predicted). Due to glycosylation, the pr
ZcytoR17, PRO21384, IL-31R-+¦, IL-31R-alpha, IL-31RA, GPL, Gp130-like receptor, GLM-RMGC125346, GLM-R, CRL3Glmr, CRL3

IL-31RA Protein, Human, Recombinant (hFc)
RHC-RP-0804
83.5 kDa (predicted)
PRO21384, PLCA2, interleukin 31 receptor A, IL-31RA, hGLM-R, GPL, GLM-R, GLMR, CRL3, CRL

IL-31RA Protein, Human, Recombinant (His)
RHC-RP-0641
58.2 kDa (predicted)
PRO21384, PLCA2, interleukin 31 receptor A, IL-31RA, hGLM-R, GPL, GLM-R, GLMR, CRL3, CRL

IL-31RA Protein, Mouse, Recombinant (His)
RHC-RP-0794
56.3 kDa (predicted). Due to glycosylation, the pr
ZcytoR17, PRO21384, IL-31R-+¦, IL-31R-alpha, IL-31RA, GPL, Gp130-like receptor, GLM-RMGC125346, GLM-R, CRL3Glmr, CRL3

IL-32 Protein, Human, Recombinant (isoform alpha, His)
RHC-CGF-0128
15.7 kDa (predicted); 20 kDa (reducing condition,
TAIFd, TAIFc, TAIFb, TAIFa, TAIF, NK4, interleukin 32, IL-32+¦, IL-32+¦, IL-32+¦, IL-32+¦, IL-32gamma, IL-32delta, IL-32beta, IL-32alpha, IL-32 Protein(isoform +¦), IL32

IL-32 Protein, Human, Recombinant (isoform beta, GST & His)
RHC-CGF-0201
49.6 kDa (predicted)
TAIF, NK4, Interleukin-32, IL-32 beta, IL-32, IL32

IL-32A Polyclonal Antibody, Biotin-Conjugate
BR00002103

IL-33 FROM MOUSE
IAR42413395

IL-33 Polyclonal Antibody, Biotin-Conjugate
BR00000561

IL-33 Protein, Canine, Recombinant
RHC-CGF-0322
17.8 kDa (predicted); 19 kDa (reducing conditions)
interleukin 33

IL-33 Protein, Cynomolgus, Recombinant
RHC-CGF-0354
18.1 kDa (predicted)
interleukin 33

IL-33 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0227
19.2 kDa (predicted). Due to glycosylation, the pr
RP11-575C20.2, NF-HEV, NFEHEV, IL33, IL1F11, DVS27, DV27, C9orf26 Z, C9ORF26

IL-33 Protein, Human, Recombinant
RHC-CGF-0137
18 kDa (predicted); 18 kDa (reducing conditions)
NF-HEV, NFEHEV, interleukin 33, IL1F11, DVS27, C9orf26

IL-33 Protein, Mouse, Recombinant
RHC-CGF-0111
18 kDa (reducing condition)
NKHEV, NF-HEV and IL- 1F11, Interleukin-1 family member 11, Interleukin 33, IL-33, IL33, DVS27, C9orf26

IL-33 Protein, Pig, Recombinant (GST)
RHC-CGF-0351
44.6 kDa (predicted)
Interleukin-33, IL-33

IL-33 Protein, Rhesus macaque, Recombinant (His)
RHC-CGF-0283
21 kDa (reducing condition)
Nuclear Factor From High Endothelial Venules, NF-HEV, NFHEV, Interleukin-33, Interleukin-1 Family Member 11, IL-33, IL33, IL-1F11, IL1F11, C9orf26

IL-33R (ST2) Monoclonal Antibody (RMST2-2), Biotin-Conjugate
BR00000249

IL-33R (ST2) Monoclonal Antibody (RMST2-33), Biotin-Conjugate
BR00000282

IL-34 Polyclonal Antibody, Biotin-Conjugate
BR00003049

IL-34 Protein, Human, Recombinant (His)
RHC-CGF-0134
26.7 kDa (predicted)
interleukin 34, IL-34, C16orf77

IL-34 Protein, Mouse, Recombinant (His)
RHC-CGF-0187
26 kDa (predicted); 38 kDa (reducing condition, du
interleukin 34, AI593503, 2010004A03Rik

IL-35 Protein, Human, Recombinant
RHC-CGF-0333
102 kDa (predicted); 60&63 kDa (reducing condition
P35, NKSF1, NFSK, Interleukin-35, interleukin 12A, IL-35, IL-12A, CLMF

IL-35 Protein, Human, Recombinant (Fc-Flag & Fc-His)
RHC-CGF-0222
102.1 kDa (predicted); 66 kDa (reducing conditions
P35, NKSF1, NFSK, Interleukin-35, interleukin 12A, IL-35, IL-12A, CLMF

IL-35 Protein, Human, Recombinant (Flag & His)
RHC-CGF-0165
48.3 kDa (predicted)
P35, NKSF1, NFSK, Interleukin-35, interleukin 12A, IL-35, IL-12A, CLMF

IL-36 alpha/IL-1F6 Protein, Human, Recombinant (aa 6-158)
RHC-CGF-0345
17 .2 kDa (predicted); 18 kDa (reducing conditions
interleukin 36, +¦, interleukin 36, alpha, IL36A, IL36 +¦/IL-1F6, IL-1F6, IL1F6, IL1E, IL1(+¦), IL1(EPSILON), FIL1E, FIL1(+¦), FIL1(EPSILON), FIL1, FIL, 1E

IL-36 alpha/IL-1F6 Protein, Human, Recombinant (His)
RHC-CGF-0328
19.2 kDa (predicted); 20 kDa (reducing conditions)
interleukin 36, +¦, interleukin 36, alpha, IL36A, IL36 +¦/IL-1F6, IL-1F6, IL1F6, IL1E, IL1(+¦), IL1(EPSILON), FIL1E, FIL1(+¦), FIL1(EPSILON), FIL1, FIL, 1E

IL-36 alpha/IL-1F6 Protein, Mouse, Recombinant
RHC-CGF-0129
18 kDa (predicted)
interleukin 36, +¦, interleukin 36, alpha, IL36 +¦/IL-1F6, IL-1F6, IL1F6, IL1(+¦), IL1(EPSILON), FIL1E, FIL1(+¦), FIL1(EPSILON), FIL1

IL-36 gamma Protein, Human, Recombinant
RHC-CGF-0343
18.9 kDa (predicted); 18 kDa (reducing conditions)
interleukin 36, +¦, interleukin 36, gamma, IL36 +¦, IL-1RP2, IL1RP2, IL-1H1, IL1H1, IL-1F9, IL1F9, IL1E

IL-36 gamma Protein, Human, Recombinant (aa 18-169)
RHC-CGF-0291
17 kDa (predicted); 16 kDa (reducing conditions)
interleukin 36, +¦, interleukin 36, gamma, IL36 +¦, IL-1RP2, IL1RP2, IL-1H1, IL1H1, IL-1F9, IL1F9, IL1E

IL-36 gamma Protein, Human, Recombinant (aa 18-169, His)
RHC-CGF-0294
19.1 kDa (predicted); 19 kDa (reducing conditions)
interleukin 36, +¦, interleukin 36, gamma, IL36 +¦, IL-1RP2, IL1RP2, IL-1H1, IL1H1, IL-1F9, IL1F9, IL1E

IL-36 gamma Protein, Mouse, Recombinant
RHC-CGF-0242
17 kDa (reducing condition)
Interleukin-36 +¦, Interleukin-36 gamma, Interleukin-1 homolog 1, IL36G, IL-36 +¦, IL-1RP2, IL-1-related protein 2, IL-1H1, IL-1F9, IL-1 +¦, IL-1 epsilon

IL-36 gamma Protein, Mouse, Recombinant (His)
RHC-CGF-0135
19.4 kDa (predicted); 20 kDa (reducing condition,
interleukin 36, +¦, interleukin 36, gamma, IL36g, IL36 +¦, Il1f9

IL-36+¦ mouse
IAR42413396

IL-36+¦ mouse
IAR42413397

IL-36+¦ mouse
IAR42413398

IL-36RN/IL-1F5 Protein, Human, Recombinant
RHC-CGF-0306
17.1 kDa (predicted); 18 kDa (reducing conditions)
PSORS14, PSORP, interleukin 36 receptor antagonist, IL36RN, IL-36Ra, IL36RA, IL1RP3, IL1L1, IL1HY1, IL1F5, FIL1D, FIL1(+¦), FIL1(DELTA), FIL1

IL-36RN/IL-1F5 Protein, Mouse, Recombinant
RHC-CGF-0163
17 kDa (predicted); 19 kDa (reducing conditions)
RP23-176J12.6, interleukin 36 receptor antagonist, Il1hy1, Il-1h3, Fil1+¦, Fil1delta, AI413231

IL-37 Monoclonal Antibody (37D12), Biotin-Conjugate
BR00000674

IL-37 Protein, Human, Recombinant
RHC-CGF-0178
18.7 kDa (predicted)
interleukin 37, IL-37, IL37, IL-1RP1, IL1RP1, IL-1H4, IL1H4, IL-1H, IL-1F7, IL1F7, FIL1Z, FIL1(+¦), FIL1(ZETA), FIL1

IL-38 Monoclonal Antibody (H127C), Biotin-Conjugate
BR00000446

IL-38 MOUSE
IAR42413399

IL-3R alpha/CD123 Protein, Canine, Recombinant (His)
RHC-CD-2581
34.2 kDa (predicted); 44 kDa (reducing conditions)
interleukin 3 receptor, +¦ (low affinity), interleukin 3 receptor, alpha (low affinity), IL-3R +¦/CD123

IL-3R alpha/CD123 Protein, Cynomolgus, Recombinant (His)
RHC-CD-2654
34.25 kDa (predicted); 54.88 kDa (reducing conditi
interleukin 3 receptor, +¦ (low affinity), interleukin 3 receptor, alpha (low affinity), IL-3R +¦/CD123

IL-3R alpha/CD123 Protein, Human, Recombinant (aa 19-305, hFc & Avi), Biotinylated
RHC-CD-2737
80-100 kDa (reducing condition)
Interleukin-3 receptor subunit +¦, Interleukin-3 receptor subunit alpha, IL-3R-+¦, IL-3R-alpha, IL-3RA, IL-3R subunit +¦, IL-3R subunit alpha, IL-3 receptor subunit +¦, IL-3 receptor subunit alpha

IL-3R alpha/CD123 Protein, Human, Recombinant (aa 19-305, His & Avi), Biotinylated
RHC-CD-2804
35.99 kDa (predicted). Due to glycosylation, the p
MGC34174, IL3RY, IL3RX, IL3RAY, IL-3Ra, IL3RA, IL-3R subunit +¦, IL-3R subunit alpha, IL3R, IL-3 R +¦/CD123, IL-3 R +¦, IL-3 R alpha, CD123

IL-3R alpha/CD123 Protein, Human, Recombinant (hFc & Avi), Biotinylated
RHC-CD-2549
61.62 kDa (predicted); 76.36 kDa (reducing conditi
interleukin 3 receptor, +¦ (low affinity), interleukin 3 receptor, alpha (low affinity), IL3RY, IL3RX, IL3RAY, IL-3R +¦/CD123, IL3R, hIL-3Ra, CD123

IL-3R alpha/CD123 Protein, Human, Recombinant (hFc)
RHC-CD-2653
59.8 kDa (predicted)
interleukin 3 receptor, +¦ (low affinity), interleukin 3 receptor, alpha (low affinity), IL3RY, IL3RX, IL3RAY, IL-3R +¦/CD123, IL3R, hIL-3Ra, CD123

IL-3R alpha/CD123 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2550
36.34 kDa (predicted); 56.42 kDa (reducing conditi
interleukin 3 receptor, +¦ (low affinity), interleukin 3 receptor, alpha (low affinity), IL3RY, IL3RX, IL3RAY, IL-3R +¦/CD123, IL3R, hIL-3Ra, CD123

IL-3R alpha/CD123 Protein, Human, Recombinant (His)
RHC-CD-2544
34.5 kDa (predicted); 50-60 kDa (reducing conditio
interleukin 3 receptor, +¦ (low affinity), interleukin 3 receptor, alpha (low affinity), IL3RY, IL3RX, IL3RAY, IL-3R +¦/CD123, IL3R, hIL-3Ra, CD123

IL-3R alpha/CD123 Protein, Mouse, Recombinant (aa 17-331, His)
RHC-CD-2625
50-65 kDa (reducing condition)
Interleukin-3 receptor subunit +¦, Interleukin-3 receptor subunit alpha, IL-3R-+¦, IL-3R-alpha, IL-3RA, IL-3R subunit +¦, IL-3R subunit alpha, IL-3 receptor subunit +¦, IL-3 receptor subunit alpha

IL-3R alpha/CD123 Protein, Mouse, Recombinant (hFc)
RHC-CD-2638
61.5 kDa (predicted)
SUT-1, interleukin 3 receptor, +¦ (low affinity), interleukin 3 receptor, alpha (low affinity), IL-3R +¦/CD123, CDw123, CD123

IL-3R alpha/CD123 Protein, Mouse, Recombinant (His)
RHC-CD-2551
35.9 kDa (predicted)
SUT-1, interleukin 3 receptor, +¦ (low affinity), interleukin 3 receptor, alpha (low affinity), IL-3R +¦/CD123, CDw123, CD123

IL-4 FROM MOUSE
IAR42413411

IL-4 HUMAN
IAR42413409

IL-4 HUMAN
IAR42413412

IL-4 Monoclonal Antibody (24G2), Biotin-Conjugate
BR00000370

IL-4 Monoclonal Antibody (25D2), Biotin-Conjugate
BR00000330

IL-4 Monoclonal Antibody (BVD6-24G2), Biotin-Conjugate
BR00000231

IL-4 Monoclonal Antibody (E10022), Biotin-Conjugate
BR00000435

IL-4 Monoclonal Antibody (MP4-25D2), Biotin-Conjugate
BR00000063

IL-4 Monoclonal Antibody (OTI25D2), Biotin-Conjugate
BR00001645

IL-4 Polyclonal Antibody, Biotin-Conjugate
BR00000421

IL-4 Protein, Canine, Recombinant
RHC-CGF-0208
13 kDa (predicted); 12-14 kDa (reducing conditions
interleukin 4

IL-4 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0315
16.03 kDa (predicted). Due to glycosylation, the p
pitrakinra, MGC79402, interleukin 4, IL-4, IL4, BSF-1, BSF1, binetrakin, BCGF-1, BCGF1, BCDF, B cell growth factor 1

IL-4 Protein, Human, Recombinant
RHC-CGF-0090
15.1 kDa (predicted)
Interleukin-4, interleukin 4, IL-4, BSF-1, BSF1, BCGF-1, BCGF1

IL-4 Protein, Human, Recombinant (hFc)
RHC-CGF-0157
40-55 kDa (reducing condition)
Pitrakinra, Lymphocyte Stimulatory Factor 1, Interleukin-4, IL-4, IL4, BSF-1, Binetrakin, B-Cell Stimulatory Factor 1

IL-4 Protein, Human, Recombinant (His & Avi)
RHC-CGF-0318
17.8 kDa (predicted). Due to glycosylation, the pr
pitrakinra, MGC79402, interleukin 4, IL-4, IL4, BSF-1, BSF1, binetrakin, BCGF-1, BCGF1, BCDF, B cell growth factor 1

IL-4 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0263
17.8 kDa (predicted). Due to glycosylation, the pr
pitrakinra, MGC79402, interleukin 4, IL-4, IL4, BSF-1, BSF1, binetrakin, BCGF-1, BCGF1, BCDF, B cell growth factor 1

IL-4 Protein, Human, Recombinant (His)
RHC-CGF-0098
18 kDa (reducing condition)
Pitrakinra, Lymphocyte Stimulatory Factor 1, Interleukin-4, IL-4, IL4, BSF-1, Binetrakin, B-Cell Stimulatory Factor 1

IL-4 Protein, Lama glama, Recombinant (His)
RHC-CGF-0246
13.8 kDa (predicted)
Lymphocyte stimulatory factor 1, Interleukin-4, IL4, B-cell stimulatory factor 1

IL-4 Protein, Mesocricetus auratus, Recombinant (His)
RHC-CGF-0205
16.3 kDa (predicted)
Lymphocyte stimulatory factor 1, Interleukin-4, IL4, B-cell stimulatory factor 1

IL-4 Protein, Mouse, Recombinant
RHC-CGF-0087
13.4 kDa (predicted); 14 kDa (reducing conditions)
interleukin 4, Il-4, BSF-1

IL-4 Protein, Sheep, Recombinant (B2M & His & Myc)
RHC-CGF-0290
29.6 kDa (predicted)
Lymphocyte stimulatory factor 1, Interleukin-4, IL4, B-cell stimulatory factor 1

IL-4 Protein, Sheep, Recombinant (His)
RHC-CGF-0241
14.6 kDa (predicted)
Lymphocyte stimulatory factor 1, Interleukin-4, IL4, B-cell stimulatory factor 1

IL-4 RECEPTOR HUMAN
IAR42413410

IL-40 Protein, Human, Recombinant (hFc)
RHC-CGF-0143
56.0 kDa (predicted)
Protein IL-40, Interleukin-40, C17orf99

IL-4R & IL2RG Heterodimer Protein, Human, Recombinant (His)
RHC-RP-0758
52.74 kDa (predicted); 47.81 kDa (reducing conditi

IL-4R alpha Protein, Mouse, Recombinant (hFc)
RHC-CD-2522
65-80 kDa (reducing condition)
Soluble IL-4R-+¦, Soluble IL-4R-alpha, Interleukin-4 receptor subunit +¦, Interleukin-4 receptor subunit alpha, IL-4R-+¦, IL-4R-alpha, IL4-BP, CD124

IL-4R Polyclonal Antibody, Biotin-Conjugate
BR00002655

IL-4R Protein, Cynomolgus, Recombinant (hFc)
RHC-CD-2538
50.48 kDa (predicted)
interleukin 4 receptor

IL-4R Protein, Cynomolgus, Recombinant (His)
RHC-CD-2787
25.2 kDa (predicted)
interleukin 4 receptor

IL-4R Protein, Human, Recombinant (hFc)
RHC-CD-2586
50.5 kDa (predicted)
interleukin 4 receptor, IL-4RA, IL4RA, IL4R, CD124

IL-4R Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2596
26.99 kDa (predicted); 47.1 kDa (reducing conditio
interleukin 4 receptor, IL-4RA, IL4RA, IL4R, CD124

IL-4R Protein, Human, Recombinant (His)
RHC-CD-2517
25.18 kDa (predicted); 43-48 kDa (reducing conditi
interleukin 4 receptor, IL-4RA, IL4RA, IL4R, CD124

IL-4R Protein, Human, Recombinant (His), Biotinylated
RHC-CD-2609
25.2 kDa (predicted)
interleukin 4 receptor, IL-4RA, IL4RA, IL4R, CD124

IL-4R Protein, Mouse, Recombinant (hFc)
RHC-CD-2676
51.1 kDa (predicted)
interleukin 4 receptor, Il4ra

IL-4R Protein, Mouse, Recombinant (His)
RHC-CD-2546
25.8 kDa (predicted)
interleukin 4 receptor, Il4ra

IL-4R Protein, Pig, Recombinant (His)
RHC-RP-0858
28.2 kDa (predicted)
Interleukin-4 receptor subunit alpha, IL4R

IL-4R Protein, Rat, Recombinant (hFc)
RHC-CD-2749
50.9 kDa (predicted); 66 kDa (reducing conditions)
interleukin 4 receptor, Il4ra, IL4R

IL-4R Protein, Rat, Recombinant (His)
RHC-CD-2818
25.3 kDa (predicted)
interleukin 4 receptor, Il4ra, IL4R

IL-5 FROM MOUSE
IAR42413273

IL-5 FROM RAT
IAR42413413

IL-5 HUMAN
IAR42413272

IL-5 Monoclonal Antibody (39D10), Biotin-Conjugate
BR00000434

IL-5 Monoclonal Antibody (JES1-5A10), Biotin-Conjugate
BR00000445

IL-5 Monoclonal Antibody (TRFK4), Biotin-Conjugate
BR00000657

IL-5 Monoclonal Antibody (TRFK5), Biotin-Conjugate
BR00000371

IL-5 Monoclonal Antibody, Biotin-Conjugate
BR00000637

IL-5 Polyclonal Antibody, Biotin-Conjugate
BR00000242

IL-5 Protein, Canine, Recombinant (His)
RHC-CGF-0266
14.54 kDa (predicted); 17-19 kDa (reducing conditi
interleukin 5

IL-5 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0352
14.6 kDa (predicted)
interleukin 5

IL-5 Protein, Human, Recombinant
RHC-CGF-0170
13.1 kDa (predicted)
TRF, interleukin 5, IL-5, EDF

IL-5 Protein, Human, Recombinant (His & Avi)
RHC-CGF-0240
16.1 kDa (predicted). Due to glycosylation, the pr
TRF, T-cell replacing factor, Interleukin-5, IL-5, EDF

IL-5 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CGF-0197
18-24 kDa (reducing condition)
TRF, T-cell replacing factor, Interleukin-5, IL-5, IL5, Eosinophil differentiation factor, B-cell differentiation factor I

IL-5 Protein, Human, Recombinant (His)
RHC-CGF-0357
14.6 kDa (predicted)
TRF, interleukin 5, IL-5, EDF

IL-5 Protein, Human, Recombinant (mFc)
RHC-CGF-0355
39.5 kDa (predicted)
TRF, interleukin 5, IL-5, EDF

IL-5 Protein, Mouse, Recombinant (His & Avi)
RHC-CGF-0224
16.03 kDa (predicted). Due to glycosylation, the p
TRF, T-cell replacing factor, Interleukin-5, IL-5, EDF

IL-5 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CGF-0200
16.0 kDa (predicted). Due to glycosylation, the pr
TRF, T-cell replacing factor, Interleukin-5, IL-5, EDF

IL-5 Protein, Mouse, Recombinant (His)
RHC-CGF-0139
14.5 kDa (predicted); 18 kDa (reducing conditions)
interleukin 5, Il-5

IL-5 Protein, Pig, Recombinant (E. coli, His)
RHC-CGF-0311
17.0 kDa (predicted)
T-cell replacing factor, Interleukin-5, IL5, Eosinophil differentiation factor

IL-5 Protein, Pig, Recombinant (His)
RHC-CGF-0295
15.0 kDa (predicted)
T-cell replacing factor, Interleukin-5, IL5, Eosinophil differentiation factor

IL-5 Rabbit Monoclonal Antibody (013), Biotin-Conjugate Recombinant
BR00000975

IL-5R alpha/CD125 Protein, Human, Recombinant (aa 21-335, His)
RHC-CD-2734
45-60 kDa (reducing condition)
Interleukin-5 receptor subunit +¦, Interleukin-5 receptor subunit alpha, IL-5R-+¦, IL-5R-alpha, IL-5RA, IL5RA, IL-5R subunit +¦, IL-5R subunit alpha, IL5R, IL-5 receptor subunit +¦, IL-5 receptor subunit alpha, CDw125, CD125

IL-5R alpha/CD125 Protein, Human, Recombinant (hFc)
RHC-CD-2733
70-85 kDa (reducing condition)
Interleukin-5 receptor subunit +¦, Interleukin-5 receptor subunit alpha, IL-5R-+¦, IL-5R-alpha, IL-5RA, IL5RA, IL-5R subunit +¦, IL-5R subunit alpha, IL5R, IL-5 receptor subunit +¦, IL-5 receptor subunit alpha, CDw125, CD125

IL-5R alpha/CD125 Protein, Human, Recombinant (His & Avi)
RHC-CD-2567
38.7 kDa (predicted). Due to glycosylation, the pr
MGC26560, IL-5Ra, IL5RA, IL-5R subunit +¦, IL-5R subunit alpha, IL5R, IL-5 R +¦/CD125, IL-5 R +¦, IL-5 R alpha, HSIL5R3, CDw125CD125, CD125

IL-5R alpha/CD125 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2805
38.7 kDa (predicted). Due to glycosylation, the pr
MGC26560, IL-5Ra, IL5RA, IL-5R subunit +¦, IL-5R subunit alpha, IL5R, IL-5 R +¦/CD125, IL-5 R +¦, IL-5 R alpha, HSIL5R3, CDw125CD125, CD125

IL-5R alpha/CD125 Protein, Human, Recombinant(aa 1-335, His)
RHC-CD-2711
37.3 kDa (predicted); 45-50 kDa (reducing conditio
interleukin 5 receptor, +¦, interleukin 5 receptor, alpha, IL5R, HSIL5R3, CDw125, CD125

IL-5R alpha/CD125 Protein, Mouse, Recombinant (His)
RHC-CD-2556
36.87 kDa (predicted); 45 kDa (reducing condition,
interleukin 5 receptor, +¦, interleukin 5 receptor, alpha, Il5r, CDw125, CD125

IL-6 FROM RAT
IAR42413417

IL-6 HUMAN
IAR42413414

IL-6 Monoclonal Antibody (505E23C7), Biotin-Conjugate
BR00000042

IL-6 Monoclonal Antibody (7IL6), Biotin-Conjugate
BR00000024

IL-6 Monoclonal Antibody (MP5-32C11), Biotin-Conjugate
BR00000041

IL-6 Monoclonal Antibody (MQ2-39C3), Biotin-Conjugate
BR00000010

IL-6 Monoclonal Antibody (OTI1D9), Biotin-Conjugate
BR00001851

IL-6 Polyclonal Antibody, Biotin-Conjugate
BR00000392

IL-6 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0223
22.06 kDa (predicted). Due to glycosylation, the p
MGI-2A, Interleukin-6, IL-6, IL6, IFN-+¦-2, IFN-beta-2, IFNB2, HSF, HGF, CDF, BSF-2

IL-6 Protein, Human, Recombinant
RHC-CGF-0096
20.95 kDa (predicted); 19.7 kDa (reducing conditio
Interleukin-6, interleukin 6, IL-6, IFNB2, HSF, HGF, BSF2

IL-6 Protein, Mouse, Recombinant
RHC-CGF-0089
21.9 kDa (predicted); 22 kDa (reducing conditions)
interleukin 6, Il-6

IL-6 Protein, Rabbit, Recombinant (His)
RHC-CGF-0245
26.4 kDa (predicted)
Interleukin-6, IL6

IL-6 Protein, Rat, Recombinant
RHC-CGF-0160
21.9 kDa (predicted); 22 kDa (reducing condition,
interleukin 6

IL-6 Protein, Rhesus, Recombinant
RHC-CGF-0349
21 kDa (predicted)
interleukin 6

IL-6 Protein, Sheep, Recombinant (GST)
RHC-CGF-0373
47.5 kDa (predicted)
Interleukin-6, IL6

IL-6 Protein, Sus scrofa (Pig), Recombinant
RHC-CGF-0211
21.2 kDa (predicted)
interleukin 6

IL-6 RECEPTOR HUMAN
IAR42413415

IL-6(88-121)(HUMAN)
CAS:145990-81-4
Formula: C₁₇₉H₂₈₁N₄₅O₅₈S
ACM145990814
H-ILE-ILE-THR-GLY-LEU-LEU-GLU-PHE-GLU-VAL-TYR-LEU-GLU-TYR-LEU-GLN-ASN-ARG-PHE-GLU-SER-SER-GLU-GLU-GLN-ALA-ARG-ALA-VAL-GLN-MET-SER-THR-LYS-OH;IL-6 (88-121) (HUMAN);INTERLEUKIN-6 (88-121) (HUMAN);interleukin-6 fragment 88-121;IL-6 (88-121);In

IL-6:IL-6R Inhibitor Screening Assay Kit
BR00028165
Interleukin 6 kit, IL6R inhibitor screening, IL6 kit, interleukin 6 receptor inhibitor screening, cytokine assay, IL-6-Biotin

IL-6R alpha/CD126 Protein, Human, Recombinant (Avi & His), Biotinylated
RHC-CD-2571
65-85 kDa (reducing condition)
Membrane glycoprotein 80, Interleukin-6 receptor subunit +¦, Interleukin-6 receptor subunit alpha, IL-6R-+¦, IL-6R-alpha, IL-6R subunit +¦, IL-6R subunit alpha, IL-6R 1, gp80, CD126

IL-6R alpha/CD126 Protein, Human, Recombinant (His & Avi)
RHC-CD-2615
41.4 kDa (predicted). Due to glycosylation, the pr
IL-6R-+¦, IL6RQ, IL-6R-alpha, IL-6RA, IL-6R subunit +¦, IL-6R subunit alpha, IL-6R 1, IL6R, IL-6 R +¦/CD126, gp80, CD126

IL-6R Protein, Canine, Recombinant (His)
RHC-CD-2759
39.8 kDa (predicted)
interleukin 6 receptor

IL-6R Protein, Human, Recombinant (hFc)
RHC-CD-2689
65.3 kDa (predicted); 70-100 kDa (reducing conditi
interleukin 6 receptor, IL6RQ, IL-6RA, IL6RA, IL-6R-1, IL-6R, IL6Q, gp80, CD126

IL-6R Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-2645
41.80 kDa (predicted); 60.56 kDa (reducing conditi
interleukin 6 receptor, IL6RQ, IL-6RA, IL6RA, IL-6R-1, IL-6R, IL6Q, gp80, CD126

IL-6R Protein, Human, Recombinant (His)
RHC-CD-2666
40 kDa (predicted); 60-65 kDa (reducing condition,
interleukin 6 receptor, IL6RQ, IL-6RA, IL6RA, IL-6R-1, IL-6R, IL6Q, gp80, CD126

IL-6R Protein, Human, Recombinant, Biotinylated
RHC-CD-2582
67.1 kDa (predicted)
interleukin 6 receptor, IL6RQ, IL-6RA, IL6RA, IL-6R-1, IL-6R, IL6Q, gp80, CD126

IL-6R Protein, Mouse, Recombinant (His)
RHC-CD-2561
39 kDa (predicted); 55-60 kDa (reducing condition,
MGC30256, interleukin 6 receptor, IL-6R, Il6r, CD126

IL-6R Protein, Rat, Recombinant (hFc)
RHC-CD-2769
64.8 kDa (predicted)
interleukin 6 receptor

IL-6R Protein, Rat, Recombinant (His)
RHC-CD-2580
39.5 kDa (predicted)
interleukin 6 receptor

IL-6R Protein, Rhesus, Recombinant (His)
RHC-CD-2547
39.6 kDa (predicted)
interleukin 6 receptor

IL-7 FROM RAT
IAR42413274

IL-7 HUMAN
IAR42413420

IL-7 Polyclonal Antibody, Biotin-Conjugate
BR00000061

IL-7 Protein, Bovine, Recombinant (His)
RHC-CGF-0284
21.3 kDa (predicted)
Interleukin-7, IL7

IL-7 Protein, Human, Recombinant
RHC-CGF-0101
17.5 kDa (predicted); 16.44 kDa (reducing conditio
Interleukin-7, interleukin 7, IL-7

IL-7 Protein, Human, Recombinant (His)
RHC-CGF-0146
19-30 kDa (reducing condition)
Interleukin-7, IL-7, IL7

IL-7 Protein, Mouse, Recombinant
RHC-CGF-0100
15 kDa (predicted); 18 kDa (reducing conditions)
interleukin 7, Il-7, hlb368, A630026I06Rik

IL-7 Protein, Mouse, Recombinant (His)
RHC-CGF-0094
22-28 kDa (reducing condition)
PBGF, Lymphopoietin -1, interleukin-7, IL-7 interleukin-7, IL-7

IL-7R alpha/CD127 Protein, Cynomolgus, Recombinant (His)
RHC-CD-0130
26.3 kDa (predicted)
interleukin 7 receptor, IL7R +¦/CD127

IL-7R alpha/CD127 Protein, Human, Recombinant (hFc & His)
RHC-CD-0311
75 kDa (reducing condition)
Interleukin-7 receptor subunit +¦, Interleukin-7 receptor subunit alpha, IL-7R-+¦, IL-7R-alpha, IL7R, CD127

IL-7R alpha/CD127 Protein, Human, Recombinant (hFc)
RHC-CD-0160
51.6 kDa (predicted)
interleukin 7 receptor, ILRA, IL-7R-+¦, IL-7R-alpha, IL7RA, IL7R +¦/CD127, IL-7R, CDW127, CD127

IL-7R alpha/CD127 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-CD-0332
28.14 kDa (predicted); 48.39 kDa (reducing conditi
interleukin 7 receptor, ILRA, IL-7R-+¦, IL-7R-alpha, IL7RA, IL7R +¦/CD127, IL-7R, CDW127, CD127

IL-7R alpha/CD127 Protein, Human, Recombinant (His)
RHC-CD-0021
26.3 kDa (predicted); 44 kDa (reducing condition,
interleukin 7 receptor, ILRA, IL-7R-+¦, IL-7R-alpha, IL7RA, IL7R +¦/CD127, IL-7R, CDW127, CD127

IL-7R alpha/CD127 Protein, Mouse, Recombinant (hFc)
RHC-CD-0247
61-75 kDa (reducing condition)
Interleukin-7 receptor subunit +¦, Interleukin-7 receptor subunit alpha, IL-7R-+¦, IL-7R-alpha, IL-7RA, IL-7R subunit +¦, IL-7R subunit alpha, Il7r, IL-7 receptor subunit +¦, IL-7 receptor subunit alpha, CD127

IL-7R alpha/CD127 Protein, Mouse, Recombinant (His)
RHC-CD-0166
26.5 kDa (predicted); 34-40 kDa (reducing conditio
interleukin 7 receptor, IL-7R+¦, IL-7Ralpha, IL7R +¦/CD127, CD127

IL-7R alpha/CD127 Protein, Rat, Recombinant (His)
RHC-CD-0064
26.5 kDa (predicted); 40 and 36 kDa (reducing cond
interleukin 7 receptor, IL7R +¦/CD127

IL-7R alpha/CD127 Protein, Rat, Recombinant (mFc)
RHC-CD-0084
51.4 kDa (predicted); 65 kDa (reducing condition,
interleukin 7 receptor, IL7R +¦/CD127

IL-7RA & IL2RG Heterodimer Protein, Human, Recombinant (His)
RHC-RP-0712
55.54 kDa (predicted); 49.70 kDa (SDS-PAGE)

IL-8 (77AA) (CXCL8) HUMAN
IAR42413091

IL-8 (CXCL8) Monoclonal Antibody (790A28G2), Biotin-Conjugate
BR00000323

IL-8 (CXCL8) Monoclonal Antibody (I8-S2), Biotin-Conjugate
BR00000229

IL-8 (CXCL8) Polyclonal Antibody, Biotin-Conjugate
BR00000074

IL-8 Monoclonal Antibody (OTI8CH), Biotin-Conjugate
BR00000259

IL-8/CXCL8 Protein, Canine, Recombinant
RHC-CGF-0503
9.2 kDa (predicted); 9 kDa (reducing condition, du
chemokine (C-X-C motif) ligand 8

IL-8/CXCL8 Protein, Chicken, Recombinant
RHC-CGF-0540
9.4 kDa (predicted)
Interleukin-8, Embryo fibroblast protein 1, CXCL8, C-X-C motif chemokine 8, Chemokine (C-X-C motif) ligand 8, CEF-4

IL-8/CXCL8 Protein, Chicken, Recombinant (His)
RHC-CGF-0460
13.4 kDa (predicted)
Interleukin-8, Embryo fibroblast protein 1, CXCL8, C-X-C motif chemokine 8, Chemokine (C-X-C motif) ligand 8, CEF-4

IL-8/CXCL8 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0454
10.12 kDa (predicted). Due to glycosylation, the p
NAP-1, NAF, MONAP, MDNCF, LYNAP, LUCT, LECT, Interleukin-8, IL8/NAP1 form I, IL-8, GCP-1, GCP/IL-8 protein IV, CXCL8

IL-8/CXCL8 Protein, Human, Recombinant (aa 23-99)
RHC-CGF-0415
8 kDa (predicted); 12 kDa (reducing condition, due
NAP-1, NAP1, NAF, MONAP, MDNCF, LYNAP, LUCT, LECT, Interleukin-8, IL-8, IL8, GCP-1, GCP1, chemokine (C-X-C motif) ligand 8

IL-8/CXCL8 Protein, Human, Recombinant (aa 23-99, hFc)
RHC-CGF-0524
35.6 kDa (predicted); 40 kDa (reducing condition,
NAP-1, NAP1, NAF, MONAP, MDNCF, LYNAP, LUCT, LECT, Interleukin-8, IL-8, IL8, GCP-1, GCP1, chemokine (C-X-C motif) ligand 8

IL-8/CXCL8 Protein, Human, Recombinant (aa 28-99)
RHC-CGF-0414
8.5 kDa (predicted)
NAP-1, NAP1, NAF, MONAP, MDNCF, LYNAP, LUCT, LECT, Interleukin-8, IL-8, IL8, GCP-1, GCP1, chemokine (C-X-C motif) ligand 8

IL-8/CXCL8 Protein, Human, Recombinant (aa 28-99, hFc)
RHC-CGF-0553
35 kDa (predicted); 40 kDa (reducing condition, du
NAP-1, NAP1, NAF, MONAP, MDNCF, LYNAP, LUCT, LECT, Interleukin-8, IL-8, IL8, GCP-1, GCP1, chemokine (C-X-C motif) ligand 8

IL-8/CXCL8 Protein, Human, Recombinant (His)
RHC-CGF-0405
9.8 kDa (predicted)
NAP-1, NAP1, NAF, MONAP, MDNCF, LYNAP, LUCT, LECT, Interleukin-8, IL-8, IL8, GCP-1, GCP1, chemokine (C-X-C motif) ligand 8

IL-8/CXCL8 Protein, Rhesus, Recombinant
RHC-CGF-0494
9.3 kDa (predicted)
chemokine (C-X-C motif) ligand 8

IL-9 FROM MOUSE
IAR4248757

IL-9 FROM RAT
IAR4248759

IL-9 HUMAN
IAR4248756

IL-9 Polyclonal Antibody, Biotin-Conjugate
BR00000393

IL-9 Protein, Cynomolgus, Recombinant (His)
RHC-CGF-0199
14.01 kDa (predicted). Due to glycosylation, the p
T-cell growth factor P40, P40, Interleukin-9, IL-9, HP40, Cytokine P40

IL-9 Protein, Human, Recombinant (hFc)
RHC-CGF-0360
40.9 kDa (predicted). Due to glycosylation, the pr
T-cell growth factor P40, P40, Interleukin-9, IL-9, HP40, Cytokine P40

IL-9 Protein, Human, Recombinant (His)
RHC-CGF-0168
15.5 kDa (predicted); 19-26 kDa (reducing conditio
P40, interleukin 9, IL-9, HP40

IL-9 Protein, Mouse, Recombinant (hFc)
RHC-CGF-0258
40.9 kDa (predicted). Due to glycosylation, the pr
T-cell growth factor P40, P40, Interleukin-9, IL-9, HP40, Cytokine P40

IL-9 Protein, Mouse, Recombinant (His)
RHC-CGF-0116
15.6 kDa (predicted)
P40, interleukin 9, Il-9

IL-9 Protein, Rat, Recombinant (His)
RHC-CGF-0206
15.6 kDa (predicted)
interleukin 9

IL-9R Protein, Rat, Recombinant (His)
RHC-RP-0650
28.2 kDa (predicted); 36 kDa (reducing condition,
interleukin 9 receptor

IL-T3 Protein, Human, Recombinant (hFc)
RHC-RP-2725
52.8 kDa (predicted); 61.8 kDa (reducing condition
LIR-5, LIR5, leukocyte immunoglobulin like receptor B4, ILT-3, ILT3, CD85K

IL-T3 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-3040
29.52 kDa (predicted); 39.8 kDa (reducing conditio
LIR-5, LIR5, leukocyte immunoglobulin like receptor B4, ILT-3, ILT3, CD85K

IL-T3 Protein, Human, Recombinant (His)
RHC-RP-2685
27.7 kDa (predicted); 35-42 kDa (reducing conditio
LIR-5, LIR5, leukocyte immunoglobulin like receptor B4, ILT-3, ILT3, CD85K

IL-T3 Protein, Mouse, Recombinant (hFc)
RHC-RP-2813
50.8 kDa (predicted)
leukocyte immunoglobulin like receptor B4

IL-T3 Protein, Mouse, Recombinant (His)
RHC-RP-2726
25.5 kDa (predicted); 39.8 kDa (reducing condition
leukocyte immunoglobulin like receptor B4

IL-T4 Protein, Human, Recombinant (hFc)
RHC-RP-2689
74.8 kDa (predicted); 93 kDa (reducing condition,
MIR-10, MIR10, LIR-2, LIR2, leukocyte immunoglobulin like receptor B2, ILT-4, ILT4, CD85D

IL-T4 Protein, Human, Recombinant (His & Avi), Biotinylated
RHC-RP-2738
51.06 kDa (predicted); 63.9 kDa (reducing conditio
MIR-10, MIR10, LIR-2, LIR2, leukocyte immunoglobulin like receptor B2, ILT-4, ILT4, CD85D

IL-T4 Protein, Human, Recombinant (His)
RHC-RP-2931
49.2 kDa (predicted); 66 kDa (reducing condition,
MIR-10, MIR10, LIR-2, LIR2, leukocyte immunoglobulin like receptor B2, ILT-4, ILT4, CD85D

IL10 Monoclonal Antibody (OTI12G8), Biotin-Conjugate
BR00001644

IL10RB Polyclonal Antibody, Biotin-Conjugate
BR00002626

IL12 p35 Polyclonal Antibody, Biotin-Conjugate
BR00003039

IL12 p40 Polyclonal Antibody, Biotin-Conjugate
BR00003040

IL12A & IL12B Heterodimer Protein, Human, Recombinant (Flag & His)
RHC-CGF-0335
39.7 kDa&27.2 kDa (predicted)

IL12RB1 Protein, Human, Recombinant (hFc)
RHC-CD-2599
95-110 kDa (reducing condition)
interleukin-12 receptor +¦-1 chain, interleukin-12 receptor subunit +¦-1, interleukin-12 receptor subunit beta-1, interleukin-12 receptor beta-1 chain, IL-12R-+¦-1, IL-12R-+¦1, IL-12R-beta-1, IL-12R-BETA1, IL-12RB1, IL12RB1, IL12RB, IL-12R subu

IL12RB2 Protein, Human, Recombinant (His)
RHC-CD-2641
69.7 kDa (predicted)
Interleukin-12 receptor subunit beta-2, IL12RB2

IL12RB2 Protein, Mouse, Recombinant (hFc)
RHC-CD-2717
125-160 kDa (reducing condition)
interleukin-12 receptor +¦-2 chain, interleukin-12 receptor subunit +¦-2, interleukin-12 receptor subunit beta-2, interleukin-12 receptor beta-2 chain, IL-12R-+¦-2, IL-12R-beta-2, IL-12RB2, IL12RB2, IL-12R subunit +¦-2, IL-12R subunit beta-2, I

IL17 (IL17A) Monoclonal Antibody (OTI4D17), Biotin-Conjugate
BR00001665

IL17A Polyclonal Antibody, Biotin-Conjugate
BR00003041

IL17B Polyclonal Antibody, Biotin-Conjugate
BR00000550

IL17C Polyclonal Antibody, Biotin-Conjugate
BR00003045

IL17C1 Polyclonal Antibody, Biotin-Conjugate
BR00003044

IL17D Polyclonal Antibody, Biotin-Conjugate
BR00000600

IL17RA Polyclonal Antibody, Biotin-Conjugate
BR00003042

IL17RB Polyclonal Antibody, Biotin-Conjugate
BR00003043

IL18BP Polyclonal Antibody, Biotin-Conjugate
BR00000431

IL18RAP Polyclonal Antibody, Biotin-Conjugate
BR00003046

IL1F9 Polyclonal Antibody, Biotin-Conjugate
BR00000568

IL1RA Monoclonal Antibody (A71B 6D11), Biotin-Conjugate
BR00000298

IL1RA Polyclonal Antibody, Biotin-Conjugate
BR00000406

IL1RAP Polyclonal Antibody, Biotin-Conjugate
BR00002582

IL23 P19 Polyclonal Antibody, Biotin-Conjugate
BR00003047

IL32 Polyclonal Antibody, Biotin-Conjugate
BR00003048

IL40
CAS:1224-08-4
Trade Name: 3-amino-5,5-diphenylimidazolidine-2,4-dione
Formula: C₁₅H₁₃N₃O₂
ACM1224084
267.28262
3-amino-5,5-diphenyl-hydantoi;3-amino-5,5-diphenylhydantoin;il40;N-aminodiphenylhydantoin;3-azanyl-5,5-di(phenyl)imidazolidine-2,4-dione

IL4R (soluble) Polyclonal Antibody, Biotin-Conjugate
BR00000591

IL6 Monoclonal Antibody (OTI39C3), Biotin-Conjugate
BR00001662

Iladatuzumab vedotin
CAS:1906205-77-3
YM1906205773
DCDS0780A; RO7032005

ILAPRAZOLE
CAS:172152-36-2
Formula: C₁₉H₁₈N₄O₂S
ACM172152362
366.44
Ilaprazole;2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-6-(1H-pyrrol-1-yl)-1H-benzimidazole

ILAPRAZOLE
CAS:172152-36-2
Formula: C19H18N4O2S
YM172152362
366.44

ILAPRAZOLE
CAS:172152-36-2
Trade Name: 2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-5-pyrrol-1-yl-1H-benzimidazole
Formula: C19H18N4O2S
APS172152362
366.44

ILAPRAZOLE
CAS:172152-36-2
Formula: C19H18N4O2S
ACLC172152362
366.44 g/mol

ILAPRAZOLE
CAS:172152-36-2
Formula: C19H18N4O2S
PI172152362
366.4
2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-6-pyrrol-1-yl-1H-benzimidazole

ILAPRAZOLE
CAS:172152-36-2
Trade Name: 2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-6-pyrrol-1-yl-1H-benzimidazole
Formula: C19H18N4O2S
PR172152362
366.4
noltec; Iy 81149

ILAPRAZOLE IMPURITY 1
Formula: C27H27N5O3S
APB10580
501.61

ILAPRAZOLE IMPURITY 10
CAS:172152-35-1
Formula: C19H18N4OS
APB172152351
350.44

Ilaprazole Impurity 100
Formula: C20H20N4O2S
APB08181
380.47

Ilaprazole Impurity 101
Formula: C19H15N3O3
APB08182
333.35

Ilaprazole Impurity 102
Formula: C18H16N4O2S
APB08188
352.41

Ilaprazole Impurity 103
Formula: C20H18N5OS+
APB08183
376.46

Ilaprazole Impurity 104
Formula: C40H40N8O2S22+
APB08186
728.93

Ilaprazole Impurity 105
Formula: C40H40N8O2S32+
APB08184
760.99

Ilaprazole Impurity 106
Formula: C19H15N4OS+
APB08185
347.42

ILAPRAZOLE IMPURITY 11
Formula: C19H19N4OS+
APB10614
351.45

ILAPRAZOLE IMPURITY 12
CAS:228351-50-8
Formula: C19H19N4O+
APB228351508
319.39

ILAPRAZOLE IMPURITY 14
CAS:1018229-53-2
Formula: C11H9N3O
APB1018229532
199.21

ILAPRAZOLE IMPURITY 15
Formula: C19H17ClN4O2S
APB10610
400.88

ILAPRAZOLE IMPURITY 17
Formula: C19H17N4O3+
APB10612
349.37

ILAPRAZOLE IMPURITY 2
Formula: C27H27N5O3S
APB10605
501.61

ILAPRAZOLE IMPURITY 21
CAS:2285346-38-3
Formula: C19H16N4O3
APB2285346383
348.36

ILAPRAZOLE IMPURITY 22
CAS:2285346-39-4
Formula: C18H16N4O
APB2285346394
304.35

ILAPRAZOLE IMPURITY 23
CAS:2285346-40-7
Formula: C19H18N4OS
APB2285346407
350.44

ILAPRAZOLE IMPURITY 24
CAS:172152-37-3
Formula: C19H18N4O3S
APB172152373
382.44

ILAPRAZOLE IMPURITY 27
CAS:1298015-58-3
Formula: C18H22N4OS
APB1298015583
342.46

ILAPRAZOLE IMPURITY 28
Formula: C18H16N4O2S
APB10609
352.41

ILAPRAZOLE IMPURITY 29
Formula: C18H16N4O2S
APB10613
352.41